Exact Mass: 232.1212

Exact Mass Matches: 232.1212

Found 500 metabolites which its exact mass value is equals to given mass value 232.1212, within given mass tolerance error 0.05 dalton. Try search metabolite list with more accurate mass tolerance error 0.01 dalton.

Melatonin

N-[2-(5-methoxy-1H-indol-3-yl)ethyl]acetamide

C13H16N2O2 (232.1212)


Melatonin is a member of the class of acetamides that is acetamide in which one of the hydrogens attached to the nitrogen atom is replaced by a 2-(5-methoxy-1H-indol-3-yl)ethyl group. It is a hormone secreted by the pineal gland in humans. It has a role as a hormone, an anticonvulsant, an immunological adjuvant, a radical scavenger, a central nervous system depressant, a human metabolite, a mouse metabolite and a geroprotector. It is a member of acetamides and a member of tryptamines. It is functionally related to a tryptamine. Melatonin is a biogenic amine that is found in animals, plants and microbes. Aaron B. Lerner of Yale University is credited for naming the hormone and for defining its chemical structure in 1958. In mammals, melatonin is produced by the pineal gland. The pineal gland is small endocrine gland, about the size of a rice grain and shaped like a pine cone (hence the name), that is located in the center of the brain (rostro-dorsal to the superior colliculus) but outside the blood-brain barrier. The secretion of melatonin increases in darkness and decreases during exposure to light, thereby regulating the circadian rhythms of several biological functions, including the sleep-wake cycle. In particular, melatonin regulates the sleep-wake cycle by chemically causing drowsiness and lowering the body temperature. Melatonin is also implicated in the regulation of mood, learning and memory, immune activity, dreaming, fertility and reproduction. Melatonin is also an effective antioxidant. Most of the actions of melatonin are mediated through the binding and activation of melatonin receptors. Individuals with autism spectrum disorders (ASD) may have lower than normal levels of melatonin. A 2008 study found that unaffected parents of individuals with ASD also have lower melatonin levels, and that the deficits were associated with low activity of the ASMT gene, which encodes the last enzyme of melatonin synthesis. Reduced melatonin production has also been proposed as a likely factor in the significantly higher cancer rates in night workers. Melatonin is a hormone produced by the pineal gland that has multiple effects including somnolence, and is believed to play a role in regulation of the sleep-wake cycle. Melatonin is available over-the-counter and is reported to have beneficial effects on wellbeing and sleep. Melatonin has not been implicated in causing serum enzyme elevations or clinically apparent liver injury. Melatonin is a natural product found in Mesocricetus auratus, Ophiopogon japonicus, and other organisms with data available. Therapeutic Melatonin is a therapeutic chemically synthesized form of the pineal indole melatonin with antioxidant properties. The pineal synthesis and secretion of melatonin, a serotonin-derived neurohormone, is dependent on beta-adrenergic receptor function. Melatonin is involved in numerous biological functions including circadian rhythm, sleep, the stress response, aging, and immunity. Melatonin is a hormone involved in sleep regulatory activity, and a tryptophan-derived neurotransmitter, which inhibits the synthesis and secretion of other neurotransmitters such as dopamine and GABA. Melatonin is synthesized from serotonin intermediate in the pineal gland and the retina where the enzyme 5-hydroxyindole-O-methyltransferase, that catalyzes the last step of synthesis, is found. This hormone binds to and activates melatonin receptors and is involved in regulating the sleep and wake cycles. In addition, melatonin possesses antioxidative and immunoregulatory properties via regulating other neurotransmitters. Melatonin is a biogenic amine that is found in animals, plants and microbes. Aaron B. Lerner of Yale University is credited for naming the hormone and for defining its chemical structure in 1958. In mammals, melatonin is produced by the pineal gland. The pineal gland is small endocrine gland, about the size of a rice grain and shaped like a pine cone (hence the name), that is l... Melatonin is a biogenic amine that is found in animals, plants and microbes. Aaron B. Lerner of Yale University is credited for naming the hormone and for defining its chemical structure in 1958. In mammals, melatonin is produced by the pineal gland. The pineal gland is small endocrine gland, about the size of a rice grain and shaped like a pine cone (hence the name), that is located in the center of the brain (rostro-dorsal to the superior colliculus) but outside the blood-brain barrier. The secretion of melatonin increases in darkness and decreases during exposure to light, thereby regulating the circadian rhythms of several biological functions, including the sleep-wake cycle. In particular, melatonin regulates the sleep-wake cycle by chemically causing drowsiness and. lowering the body temperature. Melatonin is also implicated in the regulation of mood,learning and memory, immune activity, dreaming, fertility and reproduction. Melatonin is also an effective antioxidant. Most of the actions of melatonin are mediated through the binding and activation of melatonin receptors. Individuals with autism spectrum disorders(ASD) may have lower than normal levels of melatonin. A 2008 study found that unaffected parents of individuals with ASD also have lower melatonin levels, and that the deficits. were associated with low activity of the ASMT gene, which encodes the last enzyme of melatonin synthesis. Reduced melatonin production has also been proposed as a likely factor in the significantly higher cancer rates in night workers. Melatonin, also known chemically as N-acetyl-5-methoxytryptamine, is a naturally occurring compound found in animals, plants and microbes. In animals, circulating levels of the hormone melatonin vary in a daily cycle, thereby allowing the entrainment of the circadian rhythms of several biological functions. A member of the class of acetamides that is acetamide in which one of the hydrogens attached to the nitrogen atom is replaced by a 2-(5-methoxy-1H-indol-3-yl)ethyl group. It is a hormone secreted by the pineal gland in humans. Melatonin. CAS Common Chemistry. CAS, a division of the American Chemical Society, n.d. https://commonchemistry.cas.org/detail?cas_rn=73-31-4 (retrieved 2024-07-01) (CAS RN: 73-31-4). Licensed under the Attribution-Noncommercial 4.0 International License (CC BY-NC 4.0). Melatonin is a hormone made by the pineal gland that can activates melatonin receptor. Melatonin plays a role in sleep and possesses important antioxidative and anti-inflammatory properties[1][2][3]. Melatonin is a novel selective ATF-6 inhibitor and induces human hepatoma cell apoptosis through COX-2 downregulation[4]. Melatonin attenuates palmitic acid-induced (HY-N0830) mouse granulosa cells apoptosis via endoplasmic reticulum stress[5]. Melatonin is a hormone made by the pineal gland that can activates melatonin receptor. Melatonin plays a role in sleep and possesses important antioxidative and anti-inflammatory properties[1][2][3]. Melatonin is a novel selective ATF-6 inhibitor and induces human hepatoma cell apoptosis through COX-2 downregulation[4]. Melatonin attenuates palmitic acid-induced (HY-N0830) mouse granulosa cells apoptosis via endoplasmic reticulum stress[5].

   

Boc-Asn

4-amino-2-[(tert-butoxycarbonyl)amino]-4-oxobutanoic acid

C9H16N2O5 (232.1059)


KEIO_ID B023

   

Encecalin

1-(7-Methoxy-2,2-dimethyl-2H-1-benzopyran-6-yl)ethanone

C14H16O3 (232.1099)


   

N2-Succinyl-L-ornithine

(2S)-5-Amino-2-(3-carboxypropanoylamino)pentanoic acid

C9H16N2O5 (232.1059)


N2-Succinyl-L-ornithine is a substrate for Ornithine aminotransferase (mitochondrial). It can be found in Escherichia (UniProt). N2-Succinyl-L-ornithine is a substrate for Ornithine aminotransferase (mitochondrial). [HMDB]

   

SCHEMBL9237308

(2S,6S)-2-acetamido-6-aminoheptanedioic acid

C9H16N2O5 (232.1059)


   

Aminoglutethimide

3-Ethyl-3-(p-aminophenyl)-2,6-dioxopiperidine

C13H16N2O2 (232.1212)


An aromatase inhibitor that produces a state of medical adrenalectomy by blocking the production of adrenal steroids. It also blocks the conversion of androgens to estrogens. Aminoglutethimide has been used in the treatment of advanced breast and prostate cancer. It was formerly used for its weak anticonvulsant properties. (From Martindale, The Extra Pharmacopoeia, 30th ed, p454) CONFIDENCE standard compound; INTERNAL_ID 1173; DATASET 20200303_ENTACT_RP_MIX508; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 3385; ORIGINAL_PRECURSOR_SCAN_NO 3383 CONFIDENCE standard compound; INTERNAL_ID 1173; DATASET 20200303_ENTACT_RP_MIX508; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 7127; ORIGINAL_PRECURSOR_SCAN_NO 7125 CONFIDENCE standard compound; INTERNAL_ID 1173; DATASET 20200303_ENTACT_RP_MIX508; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 7145; ORIGINAL_PRECURSOR_SCAN_NO 7141 CONFIDENCE standard compound; INTERNAL_ID 1173; DATASET 20200303_ENTACT_RP_MIX508; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 3404; ORIGINAL_PRECURSOR_SCAN_NO 3402 CONFIDENCE standard compound; INTERNAL_ID 1173; DATASET 20200303_ENTACT_RP_MIX508; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 3400; ORIGINAL_PRECURSOR_SCAN_NO 3398 CONFIDENCE standard compound; INTERNAL_ID 1173; DATASET 20200303_ENTACT_RP_MIX508; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 7086; ORIGINAL_PRECURSOR_SCAN_NO 7084 CONFIDENCE standard compound; INTERNAL_ID 1173; DATASET 20200303_ENTACT_RP_MIX508; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 7154; ORIGINAL_PRECURSOR_SCAN_NO 7153 CONFIDENCE standard compound; INTERNAL_ID 1173; DATASET 20200303_ENTACT_RP_MIX508; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 3387; ORIGINAL_PRECURSOR_SCAN_NO 3385 CONFIDENCE standard compound; INTERNAL_ID 1173; DATASET 20200303_ENTACT_RP_MIX508; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 3391; ORIGINAL_PRECURSOR_SCAN_NO 3387 CONFIDENCE standard compound; INTERNAL_ID 1173; DATASET 20200303_ENTACT_RP_MIX508; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 7094; ORIGINAL_PRECURSOR_SCAN_NO 7091 CONFIDENCE standard compound; INTERNAL_ID 1173; DATASET 20200303_ENTACT_RP_MIX508; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 3376; ORIGINAL_PRECURSOR_SCAN_NO 3375 CONFIDENCE standard compound; INTERNAL_ID 1173; DATASET 20200303_ENTACT_RP_MIX508; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 7142; ORIGINAL_PRECURSOR_SCAN_NO 7138 L - Antineoplastic and immunomodulating agents > L02 - Endocrine therapy > L02B - Hormone antagonists and related agents > L02BG - Aromatase inhibitors D006730 - Hormones, Hormone Substitutes, and Hormone Antagonists > D006727 - Hormone Antagonists > D065088 - Steroid Synthesis Inhibitors D006730 - Hormones, Hormone Substitutes, and Hormone Antagonists > D006727 - Hormone Antagonists > D004965 - Estrogen Antagonists C274 - Antineoplastic Agent > C2189 - Signal Transduction Inhibitor > C129824 - Antineoplastic Protein Inhibitor D004791 - Enzyme Inhibitors > D065088 - Steroid Synthesis Inhibitors > D047072 - Aromatase Inhibitors C274 - Antineoplastic Agent > C129818 - Antineoplastic Hormonal/Endocrine Agent > C481 - Antiestrogen C274 - Antineoplastic Agent > C163758 - Targeted Therapy Agent > C1740 - Aromatase Inhibitor C147908 - Hormone Therapy Agent > C547 - Hormone Antagonist > C2355 - Anti-Adrenal C471 - Enzyme Inhibitor > C129825 - Antineoplastic Enzyme Inhibitor D000970 - Antineoplastic Agents

   

Mexicanin E

Mexicanine E

C14H16O3 (232.1099)


   

4-(Glutamylamino) butanoate

(2S)-2-amino-4-[(3-carboxypropyl)carbamoyl]butanoic acid

C9H16N2O5 (232.1059)


4-(Glutamylamino) butanoate is a polyamine that is an intermediate in putrescine degradation II. Polyamines (the most common of which are putrescine , spermidine , and spermine ), a group of positively charged small molecules present in virtually all living organisms, have been implicated in many biological processes, including binding to nucleic acids, stabilizing membranes, and stimulating several enzymes. Although polyamines are clearly necessary for optimal cell growth, a surplus of polyamines can cause inhibition of growth and protein synthesis, and thus a balance is desired between the production and breakdown of polyamines. In putrescine degradation II, 4-(Glutamylamino) butanoate is a substrate for gamma-glutamyl-gamma-aminobutyrate hydrolase (puuD) and can be generated from the hydrolysis of gamma-glutamyl-gamma-aminobutyraldehyde. [HMDB] 4-(Glutamylamino) butanoate is a polyamine that is an intermediate in putrescine degradation II. Polyamines (the most common of which are putrescine , spermidine , and spermine ), a group of positively charged small molecules present in virtually all living organisms, have been implicated in many biological processes, including binding to nucleic acids, stabilizing membranes, and stimulating several enzymes. Although polyamines are clearly necessary for optimal cell growth, a surplus of polyamines can cause inhibition of growth and protein synthesis, and thus a balance is desired between the production and breakdown of polyamines. In putrescine degradation II, 4-(Glutamylamino) butanoate is a substrate for gamma-glutamyl-gamma-aminobutyrate hydrolase (puuD) and can be generated from the hydrolysis of gamma-glutamyl-gamma-aminobutyraldehyde.

   

10-Methylthio-2-decanoic acid

2-oxo-10-methylthiodecanoic acid

C11H20O3S (232.1133)


   

gamma-Glutamyl-alpha-aminobutyrate

N-(DL-gamma-glutamyl)-2-aminobutyric acid

C9H16N2O5 (232.1059)


   

Marindinin

4-Methoxy-6-(2-phenylethyl)-5,6-dihydro-2H-pyran-2-one

C14H16O3 (232.1099)


Marindinin is found in beverages. Marindinin is found in the roots of kava (Piper methysticum). FDA advises against use of kava in food due to potential risk of severe liver damage (2002 Dihydrokavain is one of the six major kavalactones found in the kava plant; appears to contribute significantly to the anxiolytic effects of kava, based on a study in chicks. Dihydrokavain is one of the six major kavalactones found in the kava plant; appears to contribute significantly to the anxiolytic effects of kava, based on a study in chicks.

   

Threonylleucine

(2S)-2-[(2S,3R)-2-amino-3-hydroxybutanamido]-4-methylpentanoic acid

C10H20N2O4 (232.1423)


Threonylleucine is a dipeptide composed of threonine and leucine. It is an incomplete breakdown product of protein digestion or protein catabolism. Dipeptides are organic compounds containing a sequence of exactly two alpha-amino acids joined by a peptide bond. Some dipeptides are known to have physiological or cell-signalling effects although most are simply short-lived intermediates on their way to specific amino acid degradation pathways following further proteolysis.

   

3-[4-hydroxy-3-(3-methylbut-2-enyl)phenyl]prop-2-enoic acid

3-[4-hydroxy-3-(3-methylbut-2-enyl)phenyl]prop-2-enoic acid

C14H16O3 (232.1099)


   

Pterosin E

2,3-dihydro-2,4,6-Trimethyl-3-oxo-1H-indene-5-acetic acid, 9ci

C14H16O3 (232.1099)


Constituent of Pteridium aquilinum (bracken fern) leaves. Pterosin E is found in green vegetables and root vegetables. Pterosin E is found in green vegetables. Pterosin E is a constituent of Pteridium aquilinum (bracken fern) leaves.

   

L-Acetopine

5-carbamimidamido-2-[(carboxymethyl)amino]pentanoic acid

C8H16N4O4 (232.1171)


L-Acetopine is found in fats and oils. L-Acetopine is isolated from calluses of soybean plant and coHon (Gossypium hirsutum). Isolated from calluses of soybean plant and coHon (Gossypium hirsutum). L-Acetopine is found in fats and oils and pulses.

   

Spermic acid 2

3-({4-[(2-carboxyethyl)amino]butyl}amino)propanoic acid

C10H20N2O4 (232.1423)


Spermic acid 2 is a diamide which is identified as urinary metabolites. of putrescine and spermine, and was subsequently identified and quantified. in urines of healthy persons and cancer patients. Spermic acid 2 is a diamide which is identified as urinary metabolites

   

Valylaspartic acid

(2S)-2-[(2S)-2-amino-3-methylbutanamido]butanedioic acid

C9H16N2O5 (232.1059)


Valylaspartic acid is a dipeptide composed of valine and aspartic acid. It is an incomplete breakdown product of protein digestion or protein catabolism. Dipeptides are organic compounds containing a sequence of exactly two alpha-amino acids joined by a peptide bond. Some dipeptides are known to have physiological or cell-signalling effects although most are simply short-lived intermediates on their way to specific amino acid degradation pathways following further proteolysis.

   

Threonylisoleucine

(2S,3S)-2-{[(2S,3R)-2-amino-3-hydroxybutanoyl]amino}-3-methylpentanoic acid

C10H20N2O4 (232.1423)


Threonylisoleucine is a dipeptide composed of threonine and isoleucine. It is an incomplete breakdown product of protein digestion or protein catabolism. Dipeptides are organic compounds containing a sequence of exactly two alpha-amino acids joined by a peptide bond. Some dipeptides are known to have physiological or cell-signalling effects although most are simply short-lived intermediates on their way to specific amino acid degradation pathways following further proteolysis.

   

Aspartyl-Valine

2-[(2-amino-3-carboxy-1-hydroxypropylidene)amino]-3-methylbutanoic acid

C9H16N2O5 (232.1059)


Aspartyl-Valine is a dipeptide composed of aspartate and valine. It is an incomplete breakdown product of protein digestion or protein catabolism. Some dipeptides are known to have physiological or cell-signaling effects although most are simply short-lived intermediates on their way to specific amino acid degradation pathways following further proteolysis. This dipeptide has not yet been identified in human tissues or biofluids and so it is classified as an Expected metabolite.

   

Isoleucyl-Threonine

2-[(2-Amino-1-hydroxy-3-methylpentylidene)amino]-3-hydroxybutanoate

C10H20N2O4 (232.1423)


Isoleucyl-Threonine is a dipeptide composed of isoleucine and threonine. It is an incomplete breakdown product of protein digestion or protein catabolism. Some dipeptides are known to have physiological or cell-signaling effects although most are simply short-lived intermediates on their way to specific amino acid degradation pathways following further proteolysis. This dipeptide has not yet been identified in human tissues or biofluids and so it is classified as an Expected metabolite.

   

Hydroxyprolyl-Threonine

3-Hydroxy-2-{[hydroxy(4-hydroxypyrrolidin-2-yl)methylidene]amino}butanoate

C9H16N2O5 (232.1059)


Hydroxyprolyl-Threonine is a dipeptide composed of hydroxyproline and threonine. It is an incomplete breakdown product of protein digestion or protein catabolism. Some dipeptides are known to have physiological or cell-signaling effects although most are simply short-lived intermediates on their way to specific amino acid degradation pathways following further proteolysis. This dipeptide has not yet been identified in human tissues or biofluids and so it is classified as an Expected metabolite.

   

Leucyl-Threonine

2-[(2-Amino-1-hydroxy-4-methylpentylidene)amino]-3-hydroxybutanoate

C10H20N2O4 (232.1423)


Leucyl-Threonine is a dipeptide composed of leucine and threonine. It is an incomplete breakdown product of protein digestion or protein catabolism. Some dipeptides are known to have physiological or cell-signaling effects although most are simply short-lived intermediates on their way to specific amino acid degradation pathways following further proteolysis. This dipeptide has not yet been identified in human tissues or biofluids and so it is classified as an Expected metabolite.

   

Threonylhydroxyproline

(2S,4R)-1-[(2S,3R)-2-amino-3-hydroxybutanoyl]-4-hydroxypyrrolidine-2-carboxylic acid

C9H16N2O5 (232.1059)


Threonylhydroxyproline is a dipeptide composed of threonine and hydroxyproline. It is an incomplete breakdown product of protein digestion or protein catabolism. Dipeptides are organic compounds containing a sequence of exactly two alpha-amino acids joined by a peptide bond. Some dipeptides are known to have physiological or cell-signalling effects although most are simply short-lived intermediates on their way to specific amino acid degradation pathways following further proteolysis.

   

L-N-(3-Carboxypropyl)glutamine

2-amino-4-[(3-carboxypropyl)-C-hydroxycarbonimidoyl]butanoic acid

C9H16N2O5 (232.1059)


L-N-(3-Carboxypropyl)glutamine is found in root vegetables. L-N-(3-Carboxypropyl)glutamine is a constituent of beet

   

Tetrahydrofurfuryl cinnamate

(Oxolan-2-yl)methyl (2E)-3-phenylprop-2-enoic acid

C14H16O3 (232.1099)


Tetrahydrofurfuryl cinnamate is a flavouring agent with sweet vinous odou Flavouring agent with sweet vinous odour

   

gamma-Glutamyl-2-aminobutyric acid

(2S)-2-Amino-4-{[(1S)-1-carboxypropyl]-C-hydroxycarbonimidoyl}butanoate

C9H16N2O5 (232.1059)


gamma-Glutamyl-2-aminobutyric acid, also known as gamma-Glu-Abu, belongs to the class of organic compounds known as dipeptides. These are organic compounds containing a sequence of exactly two alpha-amino acids joined by a peptide bond. gamma-Glutamyl-2-aminobutyric acid has been identified in blood (PMID: 28059425).

   

(2E)-2-[[(Z)-3-Phenylbut-2-enyl]hydrazinylidene]propanoic acid

(2E)-2-[[(Z)-3-Phenylbut-2-enyl]hydrazinylidene]propanoic acid

C13H16N2O2 (232.1212)


   

1,1-Diphenylhexatriene

(1-phenylhexa-1,3,5-trien-1-yl)benzene

C18H16 (232.1252)


   

1,6-Diphenyl-1,3,5-hexatriene

(6-phenylhexa-1,3,5-trien-1-yl)benzene

C18H16 (232.1252)


   

N-[2-(5-Methoxy-3H-indol-3-yl)ethyl]acetamide

N-[2-(5-Methoxy-3H-indol-3-yl)ethyl]acetamide

C13H16N2O2 (232.1212)


   

Ethyl L-tryptophanate

Tryptophan ethyl ester, alpha-14C-labeled CPD (DL)-isomer

C13H16N2O2 (232.1212)


   

gamma-Aminobutyric acid glutamate

4-amino-5-[(4-aminobutanoyl)oxy]-5-oxopentanoic acid

C9H16N2O5 (232.1059)


   

Mofebutazone

4-butyl-3-hydroxy-1-phenyl-4,5-dihydro-1H-pyrazol-5-one

C13H16N2O2 (232.1212)


M - Musculo-skeletal system > M02 - Topical products for joint and muscular pain > M02A - Topical products for joint and muscular pain > M02AA - Antiinflammatory preparations, non-steroids for topical use M - Musculo-skeletal system > M01 - Antiinflammatory and antirheumatic products > M01A - Antiinflammatory and antirheumatic products, non-steroids > M01AA - Butylpyrazolidines C78272 - Agent Affecting Nervous System > C241 - Analgesic Agent > C2198 - Nonnarcotic Analgesic D018373 - Peripheral Nervous System Agents > D018689 - Sensory System Agents D002491 - Central Nervous System Agents > D000700 - Analgesics D000893 - Anti-Inflammatory Agents D018501 - Antirheumatic Agents

   

Pirmagrel

6-{imidazo[1,5-a]pyridin-5-yl}hexanoic acid

C13H16N2O2 (232.1212)


   

Thr-Leu

2-[(2-Amino-1,3-dihydroxybutylidene)amino]-4-methylpentanoate

C10H20N2O4 (232.1423)


   

1,2-dibutyrin

1-(Butanoyloxy)-3-hydroxypropan-2-yl butanoic acid

C11H20O5 (232.1311)


1,2-dibutyrin, also known as alpha,beta-dibutyrine or (2-butanoyloxy-3-hydroxypropyl) butanoate, is a member of the class of compounds known as 1,2-diacylglycerols. 1,2-diacylglycerols are diacylglycerols containing a glycerol acylated at positions 1 and 2. 1,2-dibutyrin is soluble (in water) and a very weakly acidic compound (based on its pKa). 1,2-dibutyrin can be found in a number of food items such as swede, french plantain, roman camomile, and millet, which makes 1,2-dibutyrin a potential biomarker for the consumption of these food products.

   

Marindinin

2H-Pyran-2-one, 5,6-dihydro-4-methoxy-6-(2-phenylethyl)-, (6S)-

C14H16O3 (232.1099)


Dihydrokavain is a member of 2-pyranones and an aromatic ether. Dihydrokawain is a natural product found in Piper methysticum, Alnus sieboldiana, and other organisms with data available. See also: Piper methysticum root (part of). Dihydrokavain is one of the six major kavalactones found in the kava plant; appears to contribute significantly to the anxiolytic effects of kava, based on a study in chicks. Dihydrokavain is one of the six major kavalactones found in the kava plant; appears to contribute significantly to the anxiolytic effects of kava, based on a study in chicks.

   

2HP328XN7C

1(3H)-Isobenzofuranone, 3-(3-furanyl)-3a,4,5,6-tetrahydro-3a,7-dimethyl-, (3R-cis)-

C14H16O3 (232.1099)


Fraxinellone is a member of 2-benzofurans. Fraxinellone is a natural product found in Raulinoa echinata, Melia azedarach, and other organisms with data available. Fraxinellone is isolated from the root bark of the Rutaceae plant, Dictamnus dasycarpus. Fraxinellone is a PD-L1 inhibitor and inhibits HIF-1α protein synthesis without affecting HIF-1α protein degradation. Fraxinellone has the potential to be a valuable candidate for cancer treatment by targeting PD-L1[1]. Fraxinellone is isolated from the root bark of the Rutaceae plant, Dictamnus dasycarpus. Fraxinellone is a PD-L1 inhibitor and inhibits HIF-1α protein synthesis without affecting HIF-1α protein degradation. Fraxinellone has the potential to be a valuable candidate for cancer treatment by targeting PD-L1[1]. Fraxinellone is isolated from the root bark of the Rutaceae plant, Dictamnus dasycarpus. Fraxinellone is a PD-L1 inhibitor and inhibits HIF-1α protein synthesis without affecting HIF-1α protein degradation. Fraxinellone has the potential to be a valuable candidate for cancer treatment by targeting PD-L1[1].

   

N-acetylcytisine

N-acetylcytisine

C13H16N2O2 (232.1212)


relative retention time with respect to 9-anthracene Carboxylic Acid is 0.452 relative retention time with respect to 9-anthracene Carboxylic Acid is 0.447

   

3-Furan-3-yl-3a,7-dimethyl-3a,4,5,6-tetrahydro-3H-isobenzofuran-1-one

3-Furan-3-yl-3a,7-dimethyl-3a,4,5,6-tetrahydro-3H-isobenzofuran-1-one

C14H16O3 (232.1099)


   

(-)-(R)-2-Methoxydihydroartemidin

(-)-(R)-2-Methoxydihydroartemidin

C14H16O3 (232.1099)


   

5-Methoxy-1-methylspiro[indoline-3,3-pyrrolidin]-2-one

5-Methoxy-1-methylspiro[indoline-3,3-pyrrolidin]-2-one

C13H16N2O2 (232.1212)


   
   

Pichiafuran A

(-)-Pichiafuran A

C14H16O3 (232.1099)


   

6-Chloromethyl-1,8-dimethoxy-2-methyl-2,6-octadiene

6-Chloromethyl-1,8-dimethoxy-2-methyl-2,6-octadiene

C12H21ClO2 (232.123)


   

6-Methoxytremetone

6-Methoxytremetone

C14H16O3 (232.1099)


   

Acetovanillochromene

Acetovanillochromene

C14H16O3 (232.1099)


   

6-Chloromethyl-3,8-dimethoxy-2-methyl-1,6-octadiene

6-Chloromethyl-3,8-dimethoxy-2-methyl-1,6-octadiene

C12H21ClO2 (232.123)


   

Jioglutin E

Jioglutin E

C11H20O5 (232.1311)


   

Isofraxinellone

Isofraxinellone

C14H16O3 (232.1099)


   

Lacinilene D

21,7-Dihydroxy-1-methyl-4-(1-methylethyl)-(1H)-naphthalenone

C14H16O3 (232.1099)


   

10Methylthio-2-decanoic acid

2-Oxo-10-methylthiodecaonoic acid

C11H20O3S (232.1133)


   

Melatonin

N-[2-(5-Methoxy-1H-indol-3-yl)ethyl]acetamide

C13H16N2O2 (232.1212)


N - Nervous system > N05 - Psycholeptics > N05C - Hypnotics and sedatives > N05CH - Melatonin receptor agonists D002491 - Central Nervous System Agents > D002492 - Central Nervous System Depressants D006730 - Hormones, Hormone Substitutes, and Hormone Antagonists > D006728 - Hormones COVID info from clinicaltrial, clinicaltrials, clinical trial, clinical trials C147908 - Hormone Therapy Agent > C548 - Therapeutic Hormone D020011 - Protective Agents > D000975 - Antioxidants C26170 - Protective Agent > C275 - Antioxidant Corona-virus Coronavirus SARS-CoV-2 COVID-19 SARS-CoV COVID19 SARS2 SARS ORIGINAL_PRECURSOR_SCAN_NO 3385; CONFIDENCE standard compound; INTERNAL_ID 961; DATASET 20200303_ENTACT_RP_MIX508; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 3387 CONFIDENCE standard compound; INTERNAL_ID 961; DATASET 20200303_ENTACT_RP_MIX508; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 3387; ORIGINAL_PRECURSOR_SCAN_NO 3385 CONFIDENCE standard compound; INTERNAL_ID 961; DATASET 20200303_ENTACT_RP_MIX508; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 3400; ORIGINAL_PRECURSOR_SCAN_NO 3398 CONFIDENCE standard compound; INTERNAL_ID 961; DATASET 20200303_ENTACT_RP_MIX508; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 3376; ORIGINAL_PRECURSOR_SCAN_NO 3375 CONFIDENCE standard compound; INTERNAL_ID 961; DATASET 20200303_ENTACT_RP_MIX502; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 3184; ORIGINAL_PRECURSOR_SCAN_NO 3183 CONFIDENCE standard compound; INTERNAL_ID 961; DATASET 20200303_ENTACT_RP_MIX508; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 3391; ORIGINAL_PRECURSOR_SCAN_NO 3387 CONFIDENCE standard compound; INTERNAL_ID 961; DATASET 20200303_ENTACT_RP_MIX502; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 3198; ORIGINAL_PRECURSOR_SCAN_NO 3196 CONFIDENCE standard compound; INTERNAL_ID 961; DATASET 20200303_ENTACT_RP_MIX508; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 7086; ORIGINAL_PRECURSOR_SCAN_NO 7084 CONFIDENCE standard compound; INTERNAL_ID 961; DATASET 20200303_ENTACT_RP_MIX502; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 7064; ORIGINAL_PRECURSOR_SCAN_NO 7062 CONFIDENCE standard compound; INTERNAL_ID 961; DATASET 20200303_ENTACT_RP_MIX502; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 7062; ORIGINAL_PRECURSOR_SCAN_NO 7059 CONFIDENCE standard compound; INTERNAL_ID 961; DATASET 20200303_ENTACT_RP_MIX502; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 7093; ORIGINAL_PRECURSOR_SCAN_NO 7090 CONFIDENCE standard compound; INTERNAL_ID 961; DATASET 20200303_ENTACT_RP_MIX502; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 7098; ORIGINAL_PRECURSOR_SCAN_NO 7096 CONFIDENCE standard compound; INTERNAL_ID 961; DATASET 20200303_ENTACT_RP_MIX502; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 7084; ORIGINAL_PRECURSOR_SCAN_NO 7082 relative retention time with respect to 9-anthracene Carboxylic Acid is 0.685 relative retention time with respect to 9-anthracene Carboxylic Acid is 0.686 relative retention time with respect to 9-anthracene Carboxylic Acid is 0.679 relative retention time with respect to 9-anthracene Carboxylic Acid is 0.682 Melatonin is a hormone made by the pineal gland that can activates melatonin receptor. Melatonin plays a role in sleep and possesses important antioxidative and anti-inflammatory properties[1][2][3]. Melatonin is a novel selective ATF-6 inhibitor and induces human hepatoma cell apoptosis through COX-2 downregulation[4]. Melatonin attenuates palmitic acid-induced (HY-N0830) mouse granulosa cells apoptosis via endoplasmic reticulum stress[5]. Melatonin is a hormone made by the pineal gland that can activates melatonin receptor. Melatonin plays a role in sleep and possesses important antioxidative and anti-inflammatory properties[1][2][3]. Melatonin is a novel selective ATF-6 inhibitor and induces human hepatoma cell apoptosis through COX-2 downregulation[4]. Melatonin attenuates palmitic acid-induced (HY-N0830) mouse granulosa cells apoptosis via endoplasmic reticulum stress[5].

   

Mebutamate

[2-(carbamoyloxymethyl)-2,3-dimethylpentyl] carbamate

C10H20N2O4 (232.1423)


N - Nervous system > N05 - Psycholeptics > N05B - Anxiolytics > N05BC - Carbamates C78272 - Agent Affecting Nervous System > C29710 - Antipsychotic Agent

   

Sorbicillin

Sorbicillin

C14H16O3 (232.1099)


   

Maybridge4_003734

Maybridge4_003734

C12H16N4O (232.1324)


   

N-Cyclohexyl-1,3-benzothiazol-2-amine

N-Cyclohexyl-1,3-benzothiazol-2-amine

C13H16N2S (232.1034)


   

1,3-Diaminopyrene

1,3-Diaminopyrene

C16H12N2 (232.1)


CONFIDENCE standard compound; INTERNAL_ID 26

   

1,8-DIAMINOPYRENE

1,8-DIAMINOPYRENE

C16H12N2 (232.1)


CONFIDENCE standard compound; INTERNAL_ID 27

   

Phomapyrone F

Phomapyrone F

C14H16O3 (232.1099)


   

lumisantonin

lumisantonin

C14H16O3 (232.1099)


   

prelunularin

prelunularin

C14H16O3 (232.1099)


   

tsugicoline L

tsugicoline L

C14H16O3 (232.1099)


   

DTXSID50541433

DTXSID50541433

C14H16O3 (232.1099)


   

n-acetyl-o-methylserotonin

n-acetyl-o-methylserotonin

C13H16N2O2 (232.1212)


   
   

CHEMBL3960807

CHEMBL3960807

C14H16O3 (232.1099)


   

methyl (4E)-6,7,9-trihydroxydec-4-enoate

methyl (4E)-6,7,9-trihydroxydec-4-enoate

C11H20O5 (232.1311)


   

2-methyl-2-butenyl p-coumarate

2-methyl-2-butenyl p-coumarate

C14H16O3 (232.1099)


   

3-(isobutyryloxymethyl)-6-methylbenzofuran|O-(2-Methylpropanoyl)-6-Methyl-3-benzofuranmethanol

3-(isobutyryloxymethyl)-6-methylbenzofuran|O-(2-Methylpropanoyl)-6-Methyl-3-benzofuranmethanol

C14H16O3 (232.1099)


   

Dehydroespeletone

Dehydroespeletone

C14H16O3 (232.1099)


   

Pichiafuran C

Pichiafuran C

C14H16O3 (232.1099)


   

Fraxinellone

NCGC00385492-01_C14H16O3_(3R,3aR)-3-(3-Furyl)-3a,7-dimethyl-3a,4,5,6-tetrahydro-2-benzofuran-1(3H)-one

C14H16O3 (232.1099)


Fraxinellone is isolated from the root bark of the Rutaceae plant, Dictamnus dasycarpus. Fraxinellone is a PD-L1 inhibitor and inhibits HIF-1α protein synthesis without affecting HIF-1α protein degradation. Fraxinellone has the potential to be a valuable candidate for cancer treatment by targeting PD-L1[1]. Fraxinellone is isolated from the root bark of the Rutaceae plant, Dictamnus dasycarpus. Fraxinellone is a PD-L1 inhibitor and inhibits HIF-1α protein synthesis without affecting HIF-1α protein degradation. Fraxinellone has the potential to be a valuable candidate for cancer treatment by targeting PD-L1[1]. Fraxinellone is isolated from the root bark of the Rutaceae plant, Dictamnus dasycarpus. Fraxinellone is a PD-L1 inhibitor and inhibits HIF-1α protein synthesis without affecting HIF-1α protein degradation. Fraxinellone has the potential to be a valuable candidate for cancer treatment by targeting PD-L1[1].

   

CHEMBL2272796

CHEMBL2272796

C14H16O3 (232.1099)


   

(6R,7R)-tetradeca-4E,12E-diene-6,7-diol-8,10-diyneal

(6R,7R)-tetradeca-4E,12E-diene-6,7-diol-8,10-diyneal

C14H16O3 (232.1099)


   

1,4,5-Trimethoxy-2-methylnaphthalene

1,4,5-Trimethoxy-2-methylnaphthalene

C14H16O3 (232.1099)


   

CHEMBL3125436

CHEMBL3125436

C14H16O3 (232.1099)


   

1-(2-hydroxy-4-methoxy-5-methylphenyl)-2,4-E,E-hexadien-1-one|1-(2-hydroxy-4-methoxy-5-methylphenyl)-E,E-2,4-hexadien-1-one

1-(2-hydroxy-4-methoxy-5-methylphenyl)-2,4-E,E-hexadien-1-one|1-(2-hydroxy-4-methoxy-5-methylphenyl)-E,E-2,4-hexadien-1-one

C14H16O3 (232.1099)


   

DTXSID80617877

DTXSID80617877

C15H17Cl (232.1019)


   
   
   

(8alpha,10beta)-form-15-Nor-4-oxo-1(5),11(13)-guaiadien-12,8-olide

(8alpha,10beta)-form-15-Nor-4-oxo-1(5),11(13)-guaiadien-12,8-olide

C14H16O3 (232.1099)


   

3-hydroxy-3-methyl-adipic acid diethyl ester|3-Hydroxy-3-methyl-adipinsaeure-diaethylester|3-Hydroxy-3-methylglutarsaeurediethylester

3-hydroxy-3-methyl-adipic acid diethyl ester|3-Hydroxy-3-methyl-adipinsaeure-diaethylester|3-Hydroxy-3-methylglutarsaeurediethylester

C11H20O5 (232.1311)


   

(2E,4E)-1-(2,6-dihydroxy-3,5-dimethyl-phenyl)hexa-2,4-dien-1-one

(2E,4E)-1-(2,6-dihydroxy-3,5-dimethyl-phenyl)hexa-2,4-dien-1-one

C14H16O3 (232.1099)


   

Spiciferone A

Spiciferone A

C14H16O3 (232.1099)


   

Spiciferinone

Spiciferinone

C14H16O3 (232.1099)


   

DTXSID80524113

DTXSID80524113

C14H16O3 (232.1099)


   

illioliganfunone D

illioliganfunone D

C14H16O3 (232.1099)


   

(2E)-3-[(2S)-2,3-dihydro-2-(2-hydroxypropan-2-yl)-1-benzofuran-5-yl]prop-2-enal|(S)-demethoxywutaiensal

(2E)-3-[(2S)-2,3-dihydro-2-(2-hydroxypropan-2-yl)-1-benzofuran-5-yl]prop-2-enal|(S)-demethoxywutaiensal

C14H16O3 (232.1099)


   

(2E)-3-[(3R)-3,4-dihydro-3-hydroxy-2,2-dimethyl-2H-chromen-6-yl]prop-2-enal|(R)-wutaipyranol A

(2E)-3-[(3R)-3,4-dihydro-3-hydroxy-2,2-dimethyl-2H-chromen-6-yl]prop-2-enal|(R)-wutaipyranol A

C14H16O3 (232.1099)


   

(-)-2,3-dihydro-7-hydroxy-6,8-dimethyl-2-[(E)-prop-1-enyl]-chroman-4-one

(-)-2,3-dihydro-7-hydroxy-6,8-dimethyl-2-[(E)-prop-1-enyl]-chroman-4-one

C14H16O3 (232.1099)


   

3(3-methoxy-5-phenylfuran-2-yl)propan-1-ol

3(3-methoxy-5-phenylfuran-2-yl)propan-1-ol

C14H16O3 (232.1099)


   

2-hydroxy-1-((S)-2-(prop-1-en-2-yl)-2,3-dihydrobenzofuran-5-yl)propan-1-one|phenostereum A

2-hydroxy-1-((S)-2-(prop-1-en-2-yl)-2,3-dihydrobenzofuran-5-yl)propan-1-one|phenostereum A

C14H16O3 (232.1099)


   

3,3-Biindole

3,3-Biindole

C16H12N2 (232.1)


   
   

1,2,3,4-tetrahydro-5-deoxypinnatanine

1,2,3,4-tetrahydro-5-deoxypinnatanine

C10H20N2O4 (232.1423)


   

benzocamphorin H

benzocamphorin H

C14H16O3 (232.1099)


   

goniomicin B

goniomicin B

C14H16O3 (232.1099)


   

goniomicin C

goniomicin C

C14H16O3 (232.1099)


   

tabchromone B

tabchromone B

C14H16O3 (232.1099)


   

commipholinone

commipholinone

C14H16O3 (232.1099)


   

Beta-Santonin

Beta-Santonin

C14H16O3 (232.1099)


   

(3S*,4R*,5S*)-5-(1,3-dihydroxy-2-methylbutyl)-4,5-dihydro-4-hydroxy-3,5-dimethylfuran-2(3H)-one|xylariolide C

(3S*,4R*,5S*)-5-(1,3-dihydroxy-2-methylbutyl)-4,5-dihydro-4-hydroxy-3,5-dimethylfuran-2(3H)-one|xylariolide C

C11H20O5 (232.1311)


   

Flourensianol

Flourensianol

C14H16O3 (232.1099)


   

(E)-3-(2,2-dimethylchroman-6-yl)-2-propenoic acid|(E)-3-(2,2-dimethylchroman-6-yl)acrylic acid|3-[(2H)-2,2-dimethyl-3,4-dihydrobenzopyran-6-yl]-2E-propenoic acid|Drupacin|dupracine

(E)-3-(2,2-dimethylchroman-6-yl)-2-propenoic acid|(E)-3-(2,2-dimethylchroman-6-yl)acrylic acid|3-[(2H)-2,2-dimethyl-3,4-dihydrobenzopyran-6-yl]-2E-propenoic acid|Drupacin|dupracine

C14H16O3 (232.1099)


   

(+/-)-pyricuol

(+/-)-pyricuol

C14H16O3 (232.1099)


   

L-Tryptophan, N-methyl-, methyl ester

L-Tryptophan, N-methyl-, methyl ester

C13H16N2O2 (232.1212)


   

SCHEMBL13902795

SCHEMBL13902795

C13H16N2O2 (232.1212)


   

Furoscrobiculin A

Furoscrobiculin A

C14H16O3 (232.1099)


   

creolophin C

creolophin C

C14H16O3 (232.1099)


   

(3R*,4S*,5S*)-4,5-dihydro-5-(1,2-dihydroxy-2-methylbutyl)-4-hydroxy-3,5-dimethylfuran-2(3H)-one|xylariolide B

(3R*,4S*,5S*)-4,5-dihydro-5-(1,2-dihydroxy-2-methylbutyl)-4-hydroxy-3,5-dimethylfuran-2(3H)-one|xylariolide B

C11H20O5 (232.1311)


   

NEOCRYPTOLEPINE

NEOCRYPTOLEPINE

C16H12N2 (232.1)


   

ethyl tryptophanate

ethyl tryptophanate

C13H16N2O2 (232.1212)


   

Demethylsuberosin

Demethylsuberosin

C14H16O3 (232.1099)


   

4-Acetyl-2,3-dihydro-2-isopropenyl-5-methoxybenzofuran

4-Acetyl-2,3-dihydro-2-isopropenyl-5-methoxybenzofuran

C14H16O3 (232.1099)


   

Sacidumol B

Sacidumol B

C14H16O3 (232.1099)


   

ACMC-20mycr

ACMC-20mycr

C14H16O3 (232.1099)


   

Macassar III

Macassar III

C14H16O3 (232.1099)


   

4-oxo-5(6),11-eudesmadien-8,12-olide|noralantolactone

4-oxo-5(6),11-eudesmadien-8,12-olide|noralantolactone

C14H16O3 (232.1099)


   

Citrusnin A

Citrusnin A

C14H16O3 (232.1099)


   

N-dimethyl-l-tryptophan

N-dimethyl-l-tryptophan

C13H16N2O2 (232.1212)


   
   
   

aminoglutethimide

Aminoglutethimide (Cytadren)

C13H16N2O2 (232.1212)


L - Antineoplastic and immunomodulating agents > L02 - Endocrine therapy > L02B - Hormone antagonists and related agents > L02BG - Aromatase inhibitors D006730 - Hormones, Hormone Substitutes, and Hormone Antagonists > D006727 - Hormone Antagonists > D065088 - Steroid Synthesis Inhibitors D006730 - Hormones, Hormone Substitutes, and Hormone Antagonists > D006727 - Hormone Antagonists > D004965 - Estrogen Antagonists C274 - Antineoplastic Agent > C2189 - Signal Transduction Inhibitor > C129824 - Antineoplastic Protein Inhibitor D004791 - Enzyme Inhibitors > D065088 - Steroid Synthesis Inhibitors > D047072 - Aromatase Inhibitors C274 - Antineoplastic Agent > C129818 - Antineoplastic Hormonal/Endocrine Agent > C481 - Antiestrogen C274 - Antineoplastic Agent > C163758 - Targeted Therapy Agent > C1740 - Aromatase Inhibitor C147908 - Hormone Therapy Agent > C547 - Hormone Antagonist > C2355 - Anti-Adrenal C471 - Enzyme Inhibitor > C129825 - Antineoplastic Enzyme Inhibitor D000970 - Antineoplastic Agents

   

(2E,4E)-1-(2,4-dihydroxy-3,5-dimethylphenyl)hexa-2,4-dien-1-one

NCGC00180484-02!(2E,4E)-1-(2,4-dihydroxy-3,5-dimethylphenyl)hexa-2,4-dien-1-one

C14H16O3 (232.1099)


   

2-hexyl-3-hydroxypentanedioic acid

NCGC00380116-01!2-hexyl-3-hydroxypentanedioic acid

C11H20O5 (232.1311)


   

N-Cyclohexyl-2-benzothiazol-amine

N-Cyclohexyl-1,3-benzothiazol-2-amine

C13H16N2S (232.1034)


CONFIDENCE standard compound; INTERNAL_ID 2879 CONFIDENCE standard compound; INTERNAL_ID 8847

   

Dihydrokavain

NCGC00169002-05_C14H16O3_(6S)-4-Methoxy-6-(2-phenylethyl)-5,6-dihydro-2H-pyran-2-one

C14H16O3 (232.1099)


Dihydrokavain is one of the six major kavalactones found in the kava plant; appears to contribute significantly to the anxiolytic effects of kava, based on a study in chicks. Dihydrokavain is one of the six major kavalactones found in the kava plant; appears to contribute significantly to the anxiolytic effects of kava, based on a study in chicks.

   

(4S,5Z,6S)-4-(2-methoxy-2-oxoethyl)-5-[2-[(E)-3-phenylprop-2-enoyl]oxyethylidene]-6-[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-4H-pyran-3-carboxylic acid

(4S,5Z,6S)-4-(2-methoxy-2-oxoethyl)-5-[2-[(E)-3-phenylprop-2-enoyl]oxyethylidene]-6-[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-4H-pyran-3-carboxylic acid

C14H16O3 (232.1099)


   

(+)-Dihydrokavain

(+)-Dihydrokavain

C14H16O3 (232.1099)


   

Threonylleucine (isomer of 925, 926)

Threonylleucine (isomer of 925, 926)

C10H20N2O4 (232.1423)


Annotation level-3

   

Threonylleucine (isomer of 809, 925)

Threonylleucine (isomer of 809, 925)

C10H20N2O4 (232.1423)


Annotation level-2

   

Threonylleucine (isomer of 809, 926)

Threonylleucine (isomer of 809, 926)

C10H20N2O4 (232.1423)


Annotation level-2

   

3-Dimethylaminoacetyl-5-methoxyindole

3-Dimethylaminoacetyl-5-methoxyindole

C13H16N2O2 (232.1212)


Origin: Plant; SubCategory_DNP: Alkaloids derived from tryptophan, Simple tryptamine alkaloids, Indole alkaloids

   

Tryptophan ethyl ester

Tryptophan ethyl ester

C13H16N2O2 (232.1212)


   

Encecalin_major

Encecalin_major

C14H16O3 (232.1099)


   

sorbicillin_major

sorbicillin_major

C14H16O3 (232.1099)


   

3,4,5,6-tetrahydro-6,6-dimethyl-spiro[isobenzofuran-1(3H),2-[2H]pyran]-3-one

3,4,5,6-tetrahydro-6,6-dimethyl-spiro[isobenzofuran-1(3H),2-[2H]pyran]-3-one

C14H16O3 (232.1099)


   
   
   
   
   
   
   

UNII:68E01P9UWH

Ethylenediamine-N,N-di-a-butyric acid

C10H20N2O4 (232.1423)


   
   

Asp-val

2-(2-amino-3-methylbutanamido)butanedioic acid

C9H16N2O5 (232.1059)


A dipeptide formed from L-alpha-aspartyl and L-valine residues.

   

Hpro-THR

1-(2-amino-3-hydroxybutanoyl)-4-hydroxypyrrolidine-2-carboxylic acid

C9H16N2O5 (232.1059)


   

Ile-THR

2-(2-amino-3-hydroxybutanamido)-3-methylpentanoic acid

C10H20N2O4 (232.1423)


   

Leu-THR

2-(2-amino-3-hydroxybutanamido)-4-methylpentanoic acid

C10H20N2O4 (232.1423)


A dipeptide composed of L-leucine and L-threonine joined by a peptide linkage.

   

THR-HPro

3-hydroxy-2-[(4-hydroxypyrrolidin-2-yl)formamido]butanoic acid

C9H16N2O5 (232.1059)


   

THR-Ile

2-(2-amino-3-methylpentanamido)-3-hydroxybutanoic acid

C10H20N2O4 (232.1423)


   

THR-Leu

2-(2-amino-4-methylpentanamido)-3-hydroxybutanoic acid

C10H20N2O4 (232.1423)


A dipeptide formed from L-threonine and L-leucine residues.

   

Val-asp

2-(2-amino-3-carboxypropanamido)-3-methylbutanoic acid

C9H16N2O5 (232.1059)


A dipeptide formed from L-valine and L-aspartic acid residues.

   

S-N-(3-Carboxypropyl)glutamine

2-amino-4-[(3-carboxypropyl)carbamoyl]butanoic acid

C9H16N2O5 (232.1059)


   

2,3-diphenylpyrazine

2,3-diphenylpyrazine

C16H12N2 (232.1)


   

fema 3320

oxolan-2-ylmethyl (2E)-3-phenylprop-2-enoate

C14H16O3 (232.1099)


   

Pterosin E

2,3-dihydro-2,4,6-Trimethyl-3-oxo-1H-indene-5-acetic acid, 9ci

C14H16O3 (232.1099)


   

L-Acetopine

5-carbamimidamido-2-[(carboxymethyl)amino]pentanoic acid

C8H16N4O4 (232.1171)


   

ETHYL 5-[3-(DIMETHYLAMINO)PROP-1-YNYL]NICOTINATE

ETHYL 5-[3-(DIMETHYLAMINO)PROP-1-YNYL]NICOTINATE

C13H16N2O2 (232.1212)


   

3-[Dimethoxy(methyl)silyl]propyl methacrylate

3-[Dimethoxy(methyl)silyl]propyl methacrylate

C10H20O4Si (232.1131)


   

N-(tert-Butoxycarbonyl)glycylglycin

N-(tert-Butoxycarbonyl)glycylglycin

C9H16N2O5 (232.1059)


   

2,2-Biphenyldiacetic acid

2,2-Biphenyldiacetic acid

C16H12N2 (232.1)


   

(R)-1-Methylmephenytoin

(R)-1-Methylmephenytoin

C13H16N2O2 (232.1212)


   

4-(4-TERT-BUTYLPHENYL)THIAZOL-2-YLAMINE

4-(4-TERT-BUTYLPHENYL)THIAZOL-2-YLAMINE

C13H16N2S (232.1034)


   

ethyl (3r,5s)-6-hydroxy-3,5-o-iso-propylidene-3,5-dihydroxyhexanoate

ethyl (3r,5s)-6-hydroxy-3,5-o-iso-propylidene-3,5-dihydroxyhexanoate

C11H20O5 (232.1311)


   

2,2,5,7-TETRAMETHYL-1-OXOINDANE-4-CARBOXYLIC ACID

2,2,5,7-TETRAMETHYL-1-OXOINDANE-4-CARBOXYLIC ACID

C14H16O3 (232.1099)


   

trans-2-Benzoylcyclohexane-1-carboxylic acid

trans-2-Benzoylcyclohexane-1-carboxylic acid

C14H16O3 (232.1099)


   

4,6(1H,5H)-Pyrimidinedione,5-ethyldihydro-5-(4-methylphenyl)-

4,6(1H,5H)-Pyrimidinedione,5-ethyldihydro-5-(4-methylphenyl)-

C13H16N2O2 (232.1212)


   

1,6-DIPHENYL-1,3,5-HEXATRIENE

1,6-DIPHENYL-1,3,5-HEXATRIENE

C18H16 (232.1252)


D019995 - Laboratory Chemicals > D007202 - Indicators and Reagents > D049408 - Luminescent Agents D004396 - Coloring Agents > D005456 - Fluorescent Dyes

   

4-[4-(2-methylpropyl)phenyl]-1,3-thiazol-2-amine

4-[4-(2-methylpropyl)phenyl]-1,3-thiazol-2-amine

C13H16N2S (232.1034)


   

5-methyl-4-(4-propan-2-ylphenyl)-1,3-thiazol-2-amine

5-methyl-4-(4-propan-2-ylphenyl)-1,3-thiazol-2-amine

C13H16N2S (232.1034)


   

Dicyclohexylphosphinous chloride

Dicyclohexylphosphinous chloride

C12H22ClP (232.1148)


   

1,6-Pyrenediamine

1,6-Pyrenediamine

C16H12N2 (232.1)


   

1 1-DITHIOBISPIPERIDINE

1 1-DITHIOBISPIPERIDINE

C10H20N2S2 (232.1068)


   

1-(2-METHYLPHENOXY)-2-PROPANOL

1-(2-METHYLPHENOXY)-2-PROPANOL

C12H16N4O (232.1324)


   

1-ETHYL-2-METHYL-1H-BENZOIMIDAZOLE-5-CARBOXYLIC ACID ETHYL ESTER

1-ETHYL-2-METHYL-1H-BENZOIMIDAZOLE-5-CARBOXYLIC ACID ETHYL ESTER

C13H16N2O2 (232.1212)


   

(1H-IMIDAZOL-4-YL)-P-TOLYL-METHANONE

(1H-IMIDAZOL-4-YL)-P-TOLYL-METHANONE

C13H16N2O2 (232.1212)


   

N-(tert-Butoxycarbonyl)-L-alanine N-Methoxy-N-MethylaMide

N-(tert-Butoxycarbonyl)-L-alanine N-Methoxy-N-MethylaMide

C10H20N2O4 (232.1423)


   

5-methyl-4-(4-propylphenyl)-1,3-thiazol-2-amine

5-methyl-4-(4-propylphenyl)-1,3-thiazol-2-amine

C13H16N2S (232.1034)


   

N-(3-(3-Hydroxyprop-1-ynyl)pyridin-2-yl)pivalamide

N-(3-(3-Hydroxyprop-1-ynyl)pyridin-2-yl)pivalamide

C13H16N2O2 (232.1212)


   

7-N-Boc-Aminoindole

7-N-Boc-Aminoindole

C13H16N2O2 (232.1212)


   

METHYL 1-(TERT-BUTYL)-1H-BENZO[D]IMIDAZOLE-5-CARBOXYLATE

METHYL 1-(TERT-BUTYL)-1H-BENZO[D]IMIDAZOLE-5-CARBOXYLATE

C13H16N2O2 (232.1212)


   

Methyl 1-tert-butyl-1H-benzo[d]imidazole-6-carboxylate

Methyl 1-tert-butyl-1H-benzo[d]imidazole-6-carboxylate

C13H16N2O2 (232.1212)


   

N-CBZ-2,5-DIAZABICYCLO[2.2.1]HEPTANE

N-CBZ-2,5-DIAZABICYCLO[2.2.1]HEPTANE

C13H16N2O2 (232.1212)


   

Cyclohexanecarboxylic acid, 4-oxo-, phenylmethyl ester

Cyclohexanecarboxylic acid, 4-oxo-, phenylmethyl ester

C14H16O3 (232.1099)


   

(-)-MENTHOXYACETYL CHLORIDE

(-)-MENTHOXYACETYL CHLORIDE

C12H21ClO2 (232.123)


   

4-[4-(2-BUTYL)PHENYL]THIAZOL-2-YLAMINE

4-[4-(2-BUTYL)PHENYL]THIAZOL-2-YLAMINE

C13H16N2S (232.1034)


   
   

(R)-6-Benzyloxymethyl-4-methyl-5,6-dihydro-pyran-2-one

(R)-6-Benzyloxymethyl-4-methyl-5,6-dihydro-pyran-2-one

C14H16O3 (232.1099)


   

DIETHYL 3-METHYLCYCLOHEX-1-ENYLPHOSPHONATE

DIETHYL 3-METHYLCYCLOHEX-1-ENYLPHOSPHONATE

C11H21O3P (232.1228)


   

3-(4-TERT-BUTYLBENZOYL)ACRYLICACID

3-(4-TERT-BUTYLBENZOYL)ACRYLICACID

C14H16O3 (232.1099)


   

3,5-Difluoro-4-propylbiphenyl

3,5-Difluoro-4-propylbiphenyl

C15H14F2 (232.1064)


   

(S)-aminoglutethimide

(-)-Aminoglutethimide

C13H16N2O2 (232.1212)


   

2-(2-morpholin-4-ylethoxy)benzonitrile

2-(2-morpholin-4-ylethoxy)benzonitrile

C13H16N2O2 (232.1212)


   

4-METHOXYCARBONYL-4-PHENYLCYCLOHEXANONE

4-METHOXYCARBONYL-4-PHENYLCYCLOHEXANONE

C14H16O3 (232.1099)


   

PIPERIDINO(2-PIPERIDINYL)METHANONE HYDROCHLORIDE

PIPERIDINO(2-PIPERIDINYL)METHANONE HYDROCHLORIDE

C11H21ClN2O (232.1342)


   
   
   
   

(S,S)-(+)-PSEUDOEPHEDRINEGLYCINAMIDE

(S,S)-(+)-PSEUDOEPHEDRINEGLYCINAMIDE

C13H16N2O2 (232.1212)


   

H-D-Orn(Boc)-OH

H-D-Orn(Boc)-OH

C10H20N2O4 (232.1423)


   

1-Boc-4-aminoindole

1-Boc-4-aminoindole

C13H16N2O2 (232.1212)


   

Naphthalene,2-(2-phenylethyl)-

Naphthalene,2-(2-phenylethyl)-

C18H16 (232.1252)


   

2-(Phenylmethyl)-1H-indole-5-carbonitrile

2-(Phenylmethyl)-1H-indole-5-carbonitrile

C16H12N2 (232.1)


   

5-PHENYL-2,3-BIPYRIDINE

5-PHENYL-2,3-BIPYRIDINE

C16H12N2 (232.1)


   

tert-butyl-(3-ethynylphenoxy)-dimethylsilane

tert-butyl-(3-ethynylphenoxy)-dimethylsilane

C14H20OSi (232.1283)


   

4-Formylphenylboronic acid pinacol cyclic ester

4-Formylphenylboronic acid pinacol cyclic ester

C13H17BO3 (232.1271)


   

3-(4,4,5,5-Tetramethyl-1,3,2-dioxaborolan-2-yl)benzaldehyde

3-(4,4,5,5-Tetramethyl-1,3,2-dioxaborolan-2-yl)benzaldehyde

C13H17BO3 (232.1271)


   

TERT-BUTYL 5-METHYL-1H-BENZO[D]IMIDAZOLE-1-CARBOXYLATE

TERT-BUTYL 5-METHYL-1H-BENZO[D]IMIDAZOLE-1-CARBOXYLATE

C13H16N2O2 (232.1212)


   

4-(4-Fluorophenyl)-6-isopropylpyrimidin-2-ol

4-(4-Fluorophenyl)-6-isopropylpyrimidin-2-ol

C13H13FN2O (232.1012)


   

4-benzoylpiperazine-1-carboxamidine

4-benzoylpiperazine-1-carboxamidine

C12H16N4O (232.1324)


   

Methyl 4-methyl-2-propyl-1H-benzimidazole-6-carboxylate

Methyl 4-methyl-2-propyl-1H-benzimidazole-6-carboxylate

C13H16N2O2 (232.1212)


   

2-phenylindole-3-acetonitrile

2-phenylindole-3-acetonitrile

C16H12N2 (232.1)


   

N-(1-CARBAMOYL-CYCLOPENTYL)-BENZAMIDE

N-(1-CARBAMOYL-CYCLOPENTYL)-BENZAMIDE

C13H16N2O2 (232.1212)


   

(CHLOROMETHYL)VINYLBENZENE

(CHLOROMETHYL)VINYLBENZENE

C13H16N2O2 (232.1212)


   

3-(2,3,5,6-TETRAMETHYLBENZOYL)ACRYLIC ACID

3-(2,3,5,6-TETRAMETHYLBENZOYL)ACRYLIC ACID

C14H16O3 (232.1099)


   

1-(3-PIPERIDINYLCARBONYL)PIPERIDINEMONOHYDROCHLORIDE

1-(3-PIPERIDINYLCARBONYL)PIPERIDINEMONOHYDROCHLORIDE

C11H21ClN2O (232.1342)


   

n-alpha-boc-(+/-)-2-amino-3-(dimethylamino)propionic acid

n-alpha-boc-(+/-)-2-amino-3-(dimethylamino)propionic acid

C10H20N2O4 (232.1423)


   

boc-aza-l-leucine

boc-aza-l-leucine

C10H20N2O4 (232.1423)


   

[3-methoxy-4-(4-methylimidazol-1-yl)phenyl]boronic acid

[3-methoxy-4-(4-methylimidazol-1-yl)phenyl]boronic acid

C11H13BN2O3 (232.1019)


   

D-Aminoglutethimide

(R)-aminoglutethimide

C13H16N2O2 (232.1212)


   

5-FLUORO-3-(1-METHYL-4-PIPERIDINYL)INDOLE

5-FLUORO-3-(1-METHYL-4-PIPERIDINYL)INDOLE

C14H17FN2 (232.1376)


   

1-BENZYL-3(R)-ETHYL-PIPERAZINE-2,5-DIONE

1-BENZYL-3(R)-ETHYL-PIPERAZINE-2,5-DIONE

C13H16N2O2 (232.1212)


   

1-BENZYL-3-ETHYL-PIPERAZINE-2,5-DIONE

1-BENZYL-3-ETHYL-PIPERAZINE-2,5-DIONE

C13H16N2O2 (232.1212)


   

tert-butyl 3-hydroxy-3-(nitromethyl)azetidine-1-carboxylate

tert-butyl 3-hydroxy-3-(nitromethyl)azetidine-1-carboxylate

C9H16N2O5 (232.1059)


   

Boc-Asn-OH-(|A-amine-15N)

Boc-Asn-OH-(|A-amine-15N)

C9H16N2O5 (232.1059)


   

TERT-BUTYL 1H-INDOL-5-YLCARBAMATE

TERT-BUTYL 1H-INDOL-5-YLCARBAMATE

C13H16N2O2 (232.1212)


   

2-Benzoxepin-1,3-dione,4,5-dihydro-4,4,7,9-tetramethyl-

2-Benzoxepin-1,3-dione,4,5-dihydro-4,4,7,9-tetramethyl-

C14H16O3 (232.1099)


   

tert-butyl 4-cyanobenzylcarbamate

tert-butyl 4-cyanobenzylcarbamate

C13H16N2O2 (232.1212)


   

(4-(2-(1H-PYRAZOL-1-YL)ETHOXY)PHENYL)BORONIC ACID

(4-(2-(1H-PYRAZOL-1-YL)ETHOXY)PHENYL)BORONIC ACID

C11H13BN2O3 (232.1019)


   

5-(5-Amino-3-(tert-butyl)-1H-pyrazol-1-yl)pyridin-2(1H)-one

5-(5-Amino-3-(tert-butyl)-1H-pyrazol-1-yl)pyridin-2(1H)-one

C12H16N4O (232.1324)


   

tert-Butyl 1H-indol-4-ylcarbamate

tert-Butyl 1H-indol-4-ylcarbamate

C13H16N2O2 (232.1212)


   

2-PHENYL-2,4-DIHYDRO-INDENO[1,2-C]PYRAZOLE

2-PHENYL-2,4-DIHYDRO-INDENO[1,2-C]PYRAZOLE

C16H12N2 (232.1)


   

(1S,2S)-2-benzoylcyclohexane-1-carboxylate

(1S,2S)-2-benzoylcyclohexane-1-carboxylate

C14H16O3 (232.1099)


   

N-Allyl-N,N-dimethyl-2-propen-1-aminium chloride - acrylamide (1: 1:1)

N-Allyl-N,N-dimethyl-2-propen-1-aminium chloride - acrylamide (1: 1:1)

C11H21ClN2O (232.1342)


   

piperidine, 1-(4-piperidinylcarbonyl)-, hydrochloride

piperidine, 1-(4-piperidinylcarbonyl)-, hydrochloride

C11H21ClN2O (232.1342)


   

tert-butyl N-[3-[methoxy(methyl)amino]-3-oxopropyl]carbamate

tert-butyl N-[3-[methoxy(methyl)amino]-3-oxopropyl]carbamate

C10H20N2O4 (232.1423)


   

5-Fluoro-2-piperazin-1-yl-quinoxaline

5-Fluoro-2-piperazin-1-yl-quinoxaline

C12H13FN4 (232.1124)


   

tert-butyl N-[(S)-cyano(phenyl)methyl]carbamate

tert-butyl N-[(S)-cyano(phenyl)methyl]carbamate

C13H16N2O2 (232.1212)


   

(6,7-DIMETHOXY-1,2,3,4-TETRAHYDRO-ISOQUINOLIN-1-YL)-ACETONITRILE

(6,7-DIMETHOXY-1,2,3,4-TETRAHYDRO-ISOQUINOLIN-1-YL)-ACETONITRILE

C13H16N2O2 (232.1212)


   

(R)-TERT-BUTYL1-(METHOXY(METHYL)AMINO)-1-OXOPROPAN-2-YLCARBAMATE

(R)-TERT-BUTYL1-(METHOXY(METHYL)AMINO)-1-OXOPROPAN-2-YLCARBAMATE

C10H20N2O4 (232.1423)


   

4-(3-OXO-CYCLOPENTYL)-BENZOIC ACID ETHYL ESTER

4-(3-OXO-CYCLOPENTYL)-BENZOIC ACID ETHYL ESTER

C14H16O3 (232.1099)


   

5-ISOPROPYL-3-METHYLTHIO-1-PHENYL-1H-PYRAZOLE

5-ISOPROPYL-3-METHYLTHIO-1-PHENYL-1H-PYRAZOLE

C13H16N2S (232.1034)


   

(S)-N-Cbz-Valinenitrile

(S)-N-Cbz-Valinenitrile

C13H16N2O2 (232.1212)


   

Trimethylsilylketene Ethyl Trimethylsilyl Acetal (mixture of isomers)

Trimethylsilylketene Ethyl Trimethylsilyl Acetal (mixture of isomers)

C10H24O2Si2 (232.1315)


   

2-(4-Methoxyphenyl)-2,5-diazaspiro[3.4]octan-1-one

2-(4-Methoxyphenyl)-2,5-diazaspiro[3.4]octan-1-one

C13H16N2O2 (232.1212)


   

2-Ethyl-8-methyl-2,8-diazaspiro[4.5]decan-1-one hydrochloride (1: 1)

2-Ethyl-8-methyl-2,8-diazaspiro[4.5]decan-1-one hydrochloride (1: 1)

C11H21ClN2O (232.1342)


   

2-DEOXY-3,4,5,6-TETRAHYDROURIDINE

2-DEOXY-3,4,5,6-TETRAHYDROURIDINE

C9H16N2O5 (232.1059)


   

3-(4-Ethoxyphenyl)-1,4-dimethyl-1H-pyrazol-5-ol

3-(4-Ethoxyphenyl)-1,4-dimethyl-1H-pyrazol-5-ol

C13H16N2O2 (232.1212)


   

N-α-BOC-(R)-2-AMINO-3-(DIMETHYLAMINO)PROPIONIC ACID

N-α-BOC-(R)-2-AMINO-3-(DIMETHYLAMINO)PROPIONIC ACID

C10H20N2O4 (232.1423)


   

Butanedinitrile,2,3-diphenyl-, (R*,S*)- (9CI)

Butanedinitrile,2,3-diphenyl-, (R*,S*)- (9CI)

C16H12N2 (232.1)


   

N-(1-cyanocyclopentyl)-3-fluorobenzamide

N-(1-cyanocyclopentyl)-3-fluorobenzamide

C13H13FN2O (232.1012)


   

1-CYCLOHEXYL-6-FLUORO-3-METHYL-1H-INDAZOLE

1-CYCLOHEXYL-6-FLUORO-3-METHYL-1H-INDAZOLE

C14H17FN2 (232.1376)


   

3-(4-FLUOROBENZYL)-5,6,7,8-TETRAHYDRO-[1,2,4]TRIAZOLO[4,3-A]PYRAZINE

3-(4-FLUOROBENZYL)-5,6,7,8-TETRAHYDRO-[1,2,4]TRIAZOLO[4,3-A]PYRAZINE

C12H13FN4 (232.1124)


   

1-[2-(4-fluorophenyl)ethyl]piperidine-4-carbonitrile

1-[2-(4-fluorophenyl)ethyl]piperidine-4-carbonitrile

C14H17FN2 (232.1376)


   

formaldehyde,2-methylphenol,phenol

formaldehyde,2-methylphenol,phenol

C14H16O3 (232.1099)


   

phenyl-7-amino-5-azaspiro[2.4]heptane-5-carboxylate

phenyl-7-amino-5-azaspiro[2.4]heptane-5-carboxylate

C13H16N2O2 (232.1212)


   

4-(2-morpholin-4-ylethoxy)benzonitrile

4-(2-morpholin-4-ylethoxy)benzonitrile

C13H16N2O2 (232.1212)


   

N-(1-cyanocyclopentyl)-2-fluorobenzamide

N-(1-cyanocyclopentyl)-2-fluorobenzamide

C13H13FN2O (232.1012)


   

(4-(2-(1H-Imidazol-1-yl)ethoxy)phenyl)boronic acid

(4-(2-(1H-Imidazol-1-yl)ethoxy)phenyl)boronic acid

C11H13BN2O3 (232.1019)


   

4,6(1H,5H)-Pyrimidinedione,dihydro-5-phenyl-5-propyl-

4,6(1H,5H)-Pyrimidinedione,dihydro-5-phenyl-5-propyl-

C13H16N2O2 (232.1212)


   

2,3-Difluoro-4-propylbipheny

2,3-Difluoro-4-propylbipheny

C15H14F2 (232.1064)


   

2-tert-butyl-1-methyl-5-nitroindole

2-tert-butyl-1-methyl-5-nitroindole

C13H16N2O2 (232.1212)


   

Ethyl 2-oxo-3-phenylcyclopentanecarboxylate

Ethyl 2-oxo-3-phenylcyclopentanecarboxylate

C14H16O3 (232.1099)


   

ethyl 2-amino-3-(1H-indol-2-yl)propanoate

ethyl 2-amino-3-(1H-indol-2-yl)propanoate

C13H16N2O2 (232.1212)


   

Di-Tert-Butyl Hydrazo dicarboxylate

Di-Tert-Butyl Hydrazo dicarboxylate

C10H20N2O4 (232.1423)


   

(S)-1-BENZYL-3-ETHYLPIPERAZINE-2,5-DIONE

(S)-1-BENZYL-3-ETHYLPIPERAZINE-2,5-DIONE

C13H16N2O2 (232.1212)


   

BENZENEACETIC ACID, 4-(CYCLOPROPYLCARBONYL)-A,A-DIMETHYL-

BENZENEACETIC ACID, 4-(CYCLOPROPYLCARBONYL)-A,A-DIMETHYL-

C14H16O3 (232.1099)


   

5-PHENYL-2,4-BIPYRIDINE

5-PHENYL-2,4-BIPYRIDINE

C16H12N2 (232.1)


   

METHYLTRIGLYCOLMETHACRYLATE

METHYLTRIGLYCOLMETHACRYLATE

C11H20O5 (232.1311)


   
   

3-CBZ-3,6-DIAZABICYCLO[3.2.0]HEPTANE

3-CBZ-3,6-DIAZABICYCLO[3.2.0]HEPTANE

C13H16N2O2 (232.1212)


   

3-(2-morpholin-4-ylethoxy)benzonitrile

3-(2-morpholin-4-ylethoxy)benzonitrile

C13H16N2O2 (232.1212)


   

11-prop-2-enylidene-5,6-dihydrodibenzo[2,1-b:2,1-f][7]annulene

11-prop-2-enylidene-5,6-dihydrodibenzo[2,1-b:2,1-f][7]annulene

C18H16 (232.1252)


   

Pirmagrel

Pirmagrel

C13H16N2O2 (232.1212)


C78275 - Agent Affecting Blood or Body Fluid > C1327 - Antiplatelet Agent D007155 - Immunologic Factors > D007166 - Immunosuppressive Agents C308 - Immunotherapeutic Agent > C574 - Immunosuppressant D004791 - Enzyme Inhibitors

   

4-CARBOETHOXYPHENYL CYCLOBUTYL KETONE

4-CARBOETHOXYPHENYL CYCLOBUTYL KETONE

C14H16O3 (232.1099)


   

(R)-3-CHLORO-2-METHYLPROPIONYLCHLORIDE

(R)-3-CHLORO-2-METHYLPROPIONYLCHLORIDE

C11H20O5 (232.1311)


   

(E)-3-(2-Formylphenyl)-2-propenoic acid 1,1-dimethyl ethyl ester

(E)-3-(2-Formylphenyl)-2-propenoic acid 1,1-dimethyl ethyl ester

C14H16O3 (232.1099)


   

N-[3-(3-DIMETHYLAMINO-1-OXO-2-PROPENYL)PHENYL]ACETAMIDE

N-[3-(3-DIMETHYLAMINO-1-OXO-2-PROPENYL)PHENYL]ACETAMIDE

C13H16N2O2 (232.1212)


   

α-Methyl-D,L-tryptophan Methyl Ester

α-Methyl-D,L-tryptophan Methyl Ester

C13H16N2O2 (232.1212)


   

1,4-BIS(3-AMINOPHENYL)BUTADIYNE

1,4-BIS(3-AMINOPHENYL)BUTADIYNE

C16H12N2 (232.1)


   

1-Boc-6-Aminoindole

1-Boc-6-Aminoindole

C13H16N2O2 (232.1212)


   

2-BENZYL-2-CARBOMETHOXYCYCLOPENTANONE

2-BENZYL-2-CARBOMETHOXYCYCLOPENTANONE

C14H16O3 (232.1099)


   
   

4-(2-Amino-4-cyano-phenyl)-butyric acid ethyl ester

4-(2-Amino-4-cyano-phenyl)-butyric acid ethyl ester

C13H16N2O2 (232.1212)


   

DL-Mandelic Acid Sodium Salt

DL-Mandelic Acid Sodium Salt

C14H16O3 (232.1099)


   

1-(4,6-Dimethylpyrimidin-2-yl)-4-ethyl-3-methyl-1H-pyrazol-5-ol

1-(4,6-Dimethylpyrimidin-2-yl)-4-ethyl-3-methyl-1H-pyrazol-5-ol

C12H16N4O (232.1324)


   

4-(Cyclohexanecarbonyl)phenylboronic acid

4-(Cyclohexanecarbonyl)phenylboronic acid

C13H17BO3 (232.1271)


   

Kavakavaresin

Kavakavaresin

C14H16O3 (232.1099)


   

Boc-D-Asparagine

Boc-D-Asparagine

C9H16N2O5 (232.1059)


(R)-4-Amino-2-((tert-butoxycarbonyl)amino)-4-oxobutanoic acid is an asparagine derivative[1].

   

2-(1,4-diazepan-1-yl)-5-methyl[1,3]oxazolo[4,5-b]pyridine(SALTDATA: FREE)

2-(1,4-diazepan-1-yl)-5-methyl[1,3]oxazolo[4,5-b]pyridine(SALTDATA: FREE)

C12H16N4O (232.1324)


   

ETHYL 5,6-DIMETHYL-1H-BENZIMIDAZOL-1-YL)ACETATE

ETHYL 5,6-DIMETHYL-1H-BENZIMIDAZOL-1-YL)ACETATE

C13H16N2O2 (232.1212)


   

6-FLUORO-2-METHYL-3-(4-PIPERIDINE)-1H-INDOLE

6-FLUORO-2-METHYL-3-(4-PIPERIDINE)-1H-INDOLE

C14H17FN2 (232.1376)


   
   

1-(5,8-dimethoxy-3,4-dihydronaphthalen-2-yl)ethanone

1-(5,8-dimethoxy-3,4-dihydronaphthalen-2-yl)ethanone

C14H16O3 (232.1099)


   

1,4-di-(pyridin-4-yl)benzene

1,4-di-(pyridin-4-yl)benzene

C16H12N2 (232.1)


   

2-Formylphenylboronic acid pinacol ester

2-Formylphenylboronic acid pinacol ester

C13H17BO3 (232.1271)


   

9-Nitro(2H9)anthracene

9-Nitro(2H9)anthracene

C14D9NO2 (232.1198)


   

N-cyanoethyl-N-acetoxyethyl aniline

N-cyanoethyl-N-acetoxyethyl aniline

C13H16N2O2 (232.1212)


   

1-CYCLOPENTYL-3-ETHYL-6-FLUORO-1H-INDAZOLE

1-CYCLOPENTYL-3-ETHYL-6-FLUORO-1H-INDAZOLE

C14H17FN2 (232.1376)


   

1-Boc-5-aminoindole

1-Boc-5-aminoindole

C13H16N2O2 (232.1212)


   

Piperazine adipate

Piperazine adipate

C10H20N2O4 (232.1423)


C254 - Anti-Infective Agent > C276 - Antiparasitic Agent > C250 - Antihelminthic Agent

   

2-Naphthalenebutanoicacid, 5,6,7,8-tetrahydro-g-oxo-

2-Naphthalenebutanoicacid, 5,6,7,8-tetrahydro-g-oxo-

C14H16O3 (232.1099)


   

1-benzyl-1H-indole-5-carbonitrile

1-benzyl-1H-indole-5-carbonitrile

C16H12N2 (232.1)


   

1-benzyl-1H-indole-6-carbonitrile(SALTDATA: FREE)

1-benzyl-1H-indole-6-carbonitrile(SALTDATA: FREE)

C16H12N2 (232.1)


   

1-benzyl-1H-indole-4-carbonitrile(SALTDATA: FREE)

1-benzyl-1H-indole-4-carbonitrile(SALTDATA: FREE)

C16H12N2 (232.1)


   

N*6*-(4-FLUORO-BENZYL)-PYRIDINE-2,3,6-TRIAMINE

N*6*-(4-FLUORO-BENZYL)-PYRIDINE-2,3,6-TRIAMINE

C12H13FN4 (232.1124)


   

1-(2-methylphenyl)-4-oxocyclohexane-1-carboxylic acid

1-(2-methylphenyl)-4-oxocyclohexane-1-carboxylic acid

C14H16O3 (232.1099)


   

1-piperidin-4-yl-4H-3,1-benzoxazin-2-one

1-piperidin-4-yl-4H-3,1-benzoxazin-2-one

C13H16N2O2 (232.1212)


   

Seletracetam

Seletracetam

C10H14F2N2O2 (232.1023)


C78272 - Agent Affecting Nervous System > C264 - Anticonvulsant Agent C26170 - Protective Agent > C1509 - Neuroprotective Agent

   

Rezatomidine

Rezatomidine

C13H16N2S (232.1034)


C78272 - Agent Affecting Nervous System > C29747 - Adrenergic Agent > C72900 - Adrenergic Antagonist

   

Tasipimidine

Tasipimidine

C13H16N2O2 (232.1212)


C78272 - Agent Affecting Nervous System > C29747 - Adrenergic Agent > C87053 - Adrenergic Agonist

   

1,2-dibutyrin

[(2S)-2-butanoyloxy-3-hydroxypropyl] butanoate

C11H20O5 (232.1311)


A dibutyrin resulting from the condensation the secondary hydroxy group and one of the primary hydroxy groups of glycerol with butyric acid.

   

DIBUTYRIN

Butanoic acid, diester with 1,2,3-propanetriol

C11H20O5 (232.1311)


A diglyceride resulting from the formal condensation of any two of the hydroxy groups of glycerol with the carboxy groups of two molecules of butanoic acid (either R1 = H and R2 = butanoyl, or R1 = butanoyl and R2 = H). A closed class.

   

L-Isoleucyl-L-threonine

L-Isoleucyl-L-threonine

C10H20N2O4 (232.1423)


   

2-(2-Cyclohexylidenehydrazinyl)benzoic acid

2-(2-Cyclohexylidenehydrazinyl)benzoic acid

C13H16N2O2 (232.1212)


   

6-Amino-3-methyl-4-(2-methylpropyl)-2,4-dihydropyrano[2,3-c]pyrazole-5-carbonitrile

6-Amino-3-methyl-4-(2-methylpropyl)-2,4-dihydropyrano[2,3-c]pyrazole-5-carbonitrile

C12H16N4O (232.1324)


   

Ethyl L-tryptophanate

Ethyl L-tryptophanate

C13H16N2O2 (232.1212)


   

2-(dimethylamino)-1-(5-methoxy-1H-indol-3-yl)ethanone

2-(dimethylamino)-1-(5-methoxy-1H-indol-3-yl)ethanone

C13H16N2O2 (232.1212)


   

1,1,1,2,2-Pentamethyl-2-(phenylethynyl)disilane

1,1,1,2,2-Pentamethyl-2-(phenylethynyl)disilane

C13H20Si2 (232.1103)


   

2-Propenoic acid, 3-ethoxy-3-[(trimethylsilyl)oxy]-, ethyl ester

2-Propenoic acid, 3-ethoxy-3-[(trimethylsilyl)oxy]-, ethyl ester

C10H20O4Si (232.1131)


   

7-(Carboxyamino)-8-amino-nonanoic acid

7-(Carboxyamino)-8-amino-nonanoic acid

C10H20N2O4 (232.1423)


   

3-(2-Aminoethyl)-4-(aminomethyl)heptanedioic acid

3-(2-Aminoethyl)-4-(aminomethyl)heptanedioic acid

C10H20N2O4 (232.1423)


   

Mofebutazone

Mofebutazone

C13H16N2O2 (232.1212)


M - Musculo-skeletal system > M02 - Topical products for joint and muscular pain > M02A - Topical products for joint and muscular pain > M02AA - Antiinflammatory preparations, non-steroids for topical use M - Musculo-skeletal system > M01 - Antiinflammatory and antirheumatic products > M01A - Antiinflammatory and antirheumatic products, non-steroids > M01AA - Butylpyrazolidines C78272 - Agent Affecting Nervous System > C241 - Analgesic Agent > C2198 - Nonnarcotic Analgesic D018373 - Peripheral Nervous System Agents > D018689 - Sensory System Agents D002491 - Central Nervous System Agents > D000700 - Analgesics D000893 - Anti-Inflammatory Agents D018501 - Antirheumatic Agents

   

(S)-2-((S)-2-Amino-3-methylbutanamido)succinic acid

(S)-2-((S)-2-Amino-3-methylbutanamido)succinic acid

C9H16N2O5 (232.1059)


   

5-[(4-Hydroxyphenyl)methyl]-3-imino-4,4-dimethylpyrrolidin-2-one

5-[(4-Hydroxyphenyl)methyl]-3-imino-4,4-dimethylpyrrolidin-2-one

C13H16N2O2 (232.1212)


   

(3R)-N-acetyl-3-hydroxy-L-arginine

(3R)-N-acetyl-3-hydroxy-L-arginine

C8H16N4O4 (232.1171)


   

(2S,3R)-2-acetamido-5-(diaminomethylideneamino)-3-hydroxypentanoic acid

(2S,3R)-2-acetamido-5-(diaminomethylideneamino)-3-hydroxypentanoic acid

C8H16N4O4 (232.1171)


   

Threoninylhydroxyproline

Threoninylhydroxyproline

C9H16N2O5 (232.1059)


   

1,1-Diphenyl-1,3,5-hexatriene

1,1-Diphenyl-1,3,5-hexatriene

C18H16 (232.1252)


   

(2E)-2-[[(E)-3-phenylbut-2-enyl]hydrazinylidene]propanoic acid

(2E)-2-[[(E)-3-phenylbut-2-enyl]hydrazinylidene]propanoic acid

C13H16N2O2 (232.1212)


   

4-Amino-5-(4-aminobutanoyloxy)-5-oxopentanoic acid

4-Amino-5-(4-aminobutanoyloxy)-5-oxopentanoic acid

C9H16N2O5 (232.1059)


   

L-Leucyl-L-threonine

L-Leucyl-L-threonine

C10H20N2O4 (232.1423)


   

N-(4-methylphenyl)carbamic acid (cyclopentylideneamino) ester

N-(4-methylphenyl)carbamic acid (cyclopentylideneamino) ester

C13H16N2O2 (232.1212)


   

(2S)-2-amino-5-[(2S)-2-aminobutanoyl]oxy-5-oxopentanoic acid

(2S)-2-amino-5-[(2S)-2-aminobutanoyl]oxy-5-oxopentanoic acid

C9H16N2O5 (232.1059)


   

(2R,3R)-2-[(3S,6R)-3-Amino-6-hydroxy-2-oxopiperidinyl]-3-hydroxybutanoic acid

(2R,3R)-2-[(3S,6R)-3-Amino-6-hydroxy-2-oxopiperidinyl]-3-hydroxybutanoic acid

C9H16N2O5 (232.1059)


   

Threonyl-4-hydroxyproline

Threonyl-4-hydroxyproline

C9H16N2O5 (232.1059)


   

N(6)-(2-hydroxyisobutyryl)-L-lysine

N(6)-(2-hydroxyisobutyryl)-L-lysine

C10H20N2O4 (232.1423)


   

2-amino-3-hydroxy-N-(2,2,4,4-tetramethylthietan-3-yl)propanamide

2-amino-3-hydroxy-N-(2,2,4,4-tetramethylthietan-3-yl)propanamide

C10H20N2O2S (232.1245)


   

(2S,3R)-2-amino-3-hydroxy-5-[(2S,4R)-4-hydroxypyrrolidin-2-yl]-5-oxopentanoic acid

(2S,3R)-2-amino-3-hydroxy-5-[(2S,4R)-4-hydroxypyrrolidin-2-yl]-5-oxopentanoic acid

C9H16N2O5 (232.1059)


   

Trimethylsilyl 4-(2,2-dimethylhydrazino)-4-oxobutanoate

Trimethylsilyl 4-(2,2-dimethylhydrazino)-4-oxobutanoate

C9H20N2O3Si (232.1243)


   

Glutaric acid, ethyltrimethylsilyl ester

Glutaric acid, ethyltrimethylsilyl ester

C10H20O4Si (232.1131)


   

Alanyl-beta-alanine, TMS derivative

Alanyl-beta-alanine, TMS derivative

C9H20N2O3Si (232.1243)


   

1,4-Bis(6-methylpyridyl-3)butadiyne

1,4-Bis(6-methylpyridyl-3)butadiyne

C16H12N2 (232.1)


   

6,6-Dimethyl-3h-spiro[2-benzofuran-1,2-oxane]-3-one

6,6-Dimethyl-3h-spiro[2-benzofuran-1,2-oxane]-3-one

C14H16O3 (232.1099)


   

4-Methoxy-4-phenyl-3-trimethylsilyl-1,2-butadiene

4-Methoxy-4-phenyl-3-trimethylsilyl-1,2-butadiene

C14H20OSi (232.1283)


   

2-Hexyl-3-hydroxypentanedioic acid

2-Hexyl-3-hydroxypentanedioic acid

C11H20O5 (232.1311)


   

(1-Acetyloxy-3-hydroxypropan-2-yl) hexanoate

(1-Acetyloxy-3-hydroxypropan-2-yl) hexanoate

C11H20O5 (232.1311)


   

(1-Hydroxy-3-propanoyloxypropan-2-yl) pentanoate

(1-Hydroxy-3-propanoyloxypropan-2-yl) pentanoate

C11H20O5 (232.1311)


   

Cryptolepine

Cryptolepine

C16H12N2 (232.1)


An organic heterotetracyclic compound that is 5H-indolo[3,2-b]quinoline in which the hydrogen at position N-5 is replaced by a methyl group. D000890 - Anti-Infective Agents > D000977 - Antiparasitic Agents > D000981 - Antiprotozoal Agents

   

BOC-L-Asparagine

tert-Butoxycarbonylasparagine

C9H16N2O5 (232.1059)


   

N2-Succinyl-L-ornithine

N(2)-succinyl-L-ornithine

C9H16N2O5 (232.1059)


   

2-oxo-10-methylthiodecanoic acid

2-oxo-10-methylthiodecanoic acid

C11H20O3S (232.1133)


   

(2S,6S)-2-acetamido-6-aminoheptanedioic acid

(2S,6S)-2-acetamido-6-aminoheptanedioic acid

C9H16N2O5 (232.1059)


   

gamma-Glutamyl-gaba

4-(gamma-L-Glutamylamino)butanoate

C9H16N2O5 (232.1059)


   

[(2S)-2-butanoyloxy-3-hydroxypropyl] butanoate

[(2S)-2-butanoyloxy-3-hydroxypropyl] butanoate

C11H20O5 (232.1311)


   

Isoleucylthreonine

Isoleucylthreonine

C10H20N2O4 (232.1423)


   

Threonylisoleucine

Threonylisoleucine

C10H20N2O4 (232.1423)


   
   

N-(1-carboxypropyl)glutamine

N-(1-carboxypropyl)glutamine

C9H16N2O5 (232.1059)


   

Hydroxyprolyl-Threonine

Hydroxyprolyl-Threonine

C9H16N2O5 (232.1059)


   

1,3-dibutyrin

1,3-dibutyrin

C11H20O5 (232.1311)


A dibutyrin resulting from the condensation of both of the primary hydroxy groups of glycerol with butyric acid.

   

Threoninyl-Isoleucine

Threoninyl-Isoleucine

C10H20N2O4 (232.1423)


   

Threoninyl-hydroxyproline

Threoninyl-hydroxyproline

C9H16N2O5 (232.1059)


   

4-(L-gamma-glutamylamino)Butanoic acid

4-(L-gamma-glutamylamino)Butanoic acid

C9H16N2O5 (232.1059)


An N-acyl-gamma-aminobutyric acid resulting from the formal condensation of the amino group of 4-aminobutanoic acid with the gamma-carbxy group of L-glutamic acid.

   

8-Amino-7-(carboxyamino)nonanoate

8-amino-7-(carboxyamino)nonanoic acid

C10H20N2O4 (232.1423)


8-Amino-7-(carboxyamino)nonanoate is an organic compound that belongs to the class of amino acid derivatives. In this molecule, the amino group (-NH2) and the carboxy group (-COOH) are typical functional groups found in amino acids, and they are attached to the 8th and 7th carbon atoms of a nonanoic acid chain, respectively. Nonanoic acid is a nine-carbon fatty acid, and the presence of these functional groups at specific positions on the chain modifies its chemical properties, making it distinct from simple nonanoic acid. The compound's chemical formula is C11H22N2O4, indicating that it contains 11 carbon atoms, 22 hydrogen atoms, 2 nitrogen atoms, and 4 oxygen atoms. The amino and carboxy groups are both polar, which means that 8-Amino-7-(carboxyamino)nonanoate is likely to be soluble in water and may participate in various chemical reactions typical of amino acids, such as peptide bond formation. In biological systems, amino acids and their derivatives play crucial roles in protein synthesis, metabolism, and signaling. The specific functions of 8-Amino-7-(carboxyamino)nonanoate would depend on its occurrence in nature, if any, and how it interacts with other biomolecules. If this compound is not naturally occurring, it could be synthesized in a laboratory setting or potentially produced by microorganisms through metabolic engineering, where the organisms are genetically modified to produce specific compounds.

   

Glutamylamino butanoate

Glutamylamino butanoate

C9H16N2O5 (232.1059)


   

N2-Succinylornithine

N2-Succinylornithine

C9H16N2O5 (232.1059)


   

gamma-Glutamyl-2-aminobutanoate

gamma-Glutamyl-2-aminobutanoate

C9H16N2O5 (232.1059)


   

Drupanin

Drupanin

C14H16O3 (232.1099)


Drupanin is a compound isolated from green propolis. Drupanin can selectively inhibit the AKR1C3 enzyme. Drupanin has the potential for the research of breast cancer[1].

   

3-[4-hydroxy-3-(3-methylbut-2-en-1-yl)phenyl]prop-2-enoic acid

3-[4-hydroxy-3-(3-methylbut-2-en-1-yl)phenyl]prop-2-enoic acid

C14H16O3 (232.1099)


   

(1r,9s)-11-acetyl-7,11-diazatricyclo[7.3.1.0²,⁷]trideca-2,4-dien-6-one

(1r,9s)-11-acetyl-7,11-diazatricyclo[7.3.1.0²,⁷]trideca-2,4-dien-6-one

C13H16N2O2 (232.1212)


   

3-(penta-1,3-dien-1-yl)-3,4-dihydro-1h-2-benzopyran-4,8-diol

3-(penta-1,3-dien-1-yl)-3,4-dihydro-1h-2-benzopyran-4,8-diol

C14H16O3 (232.1099)


   

(2e,4e)-1-(2-hydroxy-4-methoxy-5-methylphenyl)hexa-2,4-dien-1-one

(2e,4e)-1-(2-hydroxy-4-methoxy-5-methylphenyl)hexa-2,4-dien-1-one

C14H16O3 (232.1099)


   

n-[(2s)-1-hydroxy-3-(1h-indol-3-yl)propan-2-yl]ethanimidic acid

n-[(2s)-1-hydroxy-3-(1h-indol-3-yl)propan-2-yl]ethanimidic acid

C13H16N2O2 (232.1212)


   

(2s)-2-(dimethylamino)-3-(1h-indol-3-yl)propanoic acid

(2s)-2-(dimethylamino)-3-(1h-indol-3-yl)propanoic acid

C13H16N2O2 (232.1212)


   

1-[(2r)-6-methoxy-2-(prop-1-en-2-yl)-2,3-dihydro-1-benzofuran-5-yl]ethanone

1-[(2r)-6-methoxy-2-(prop-1-en-2-yl)-2,3-dihydro-1-benzofuran-5-yl]ethanone

C14H16O3 (232.1099)


   

(8r)-8-ethyl-2,3,8-trimethylchromene-4,7-dione

(8r)-8-ethyl-2,3,8-trimethylchromene-4,7-dione

C14H16O3 (232.1099)


   

(3r,3ar)-3-(furan-3-yl)-3a,7-dimethyl-3,4,5,7a-tetrahydro-2-benzofuran-1-one

(3r,3ar)-3-(furan-3-yl)-3a,7-dimethyl-3,4,5,7a-tetrahydro-2-benzofuran-1-one

C14H16O3 (232.1099)


   

6-hydroxy-5-isopropyl-3,8-dimethylchromen-2-one

6-hydroxy-5-isopropyl-3,8-dimethylchromen-2-one

C14H16O3 (232.1099)


   

(4s)-4-hydroxy-3-[2-(4-hydroxyphenyl)ethyl]cyclohex-2-en-1-one

(4s)-4-hydroxy-3-[2-(4-hydroxyphenyl)ethyl]cyclohex-2-en-1-one

C14H16O3 (232.1099)


   

5-(1,3-dihydroxy-2-methylbutyl)-4-hydroxy-3,5-dimethyloxolan-2-one

5-(1,3-dihydroxy-2-methylbutyl)-4-hydroxy-3,5-dimethyloxolan-2-one

C11H20O5 (232.1311)


   

5,10-dimethyl-3-oxatetracyclo[7.4.0.0¹,¹⁰.0²,⁶]tridec-12-ene-4,11-dione

5,10-dimethyl-3-oxatetracyclo[7.4.0.0¹,¹⁰.0²,⁶]tridec-12-ene-4,11-dione

C14H16O3 (232.1099)


   

4-methoxy-3,5,6,8-tetramethylchromen-2-one

4-methoxy-3,5,6,8-tetramethylchromen-2-one

C14H16O3 (232.1099)


   

(3r,4e,6e,12e)-tetradeca-4,6,12-trien-8,10-diyne-1,3,14-triol

(3r,4e,6e,12e)-tetradeca-4,6,12-trien-8,10-diyne-1,3,14-triol

C14H16O3 (232.1099)


   

1-[5-methoxy-2-(prop-1-en-2-yl)-2,3-dihydro-1-benzofuran-4-yl]ethanone

1-[5-methoxy-2-(prop-1-en-2-yl)-2,3-dihydro-1-benzofuran-4-yl]ethanone

C14H16O3 (232.1099)


   

1,3-dimethoxy-6,7-dimethylnaphthalen-2-ol

1,3-dimethoxy-6,7-dimethylnaphthalen-2-ol

C14H16O3 (232.1099)


   

atractylentriol

NA

C14H16O3 (232.1099)


{"Ingredient_id": "HBIN017289","Ingredient_name": "atractylentriol","Alias": "NA","Ingredient_formula": "C14H16O3","Ingredient_Smile": "C(CO)C(C=CC=CC#CC#CC=CCO)O","Ingredient_weight": "NA","OB_score": "NA","CAS_id": "NA","SymMap_id": "SMIT14416","TCMID_id": "1968","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "NA","DrugBank_id": "NA"}

   

(2r)-7-hydroxy-6,8-dimethyl-2-[(1e)-prop-1-en-1-yl]-2,3-dihydro-1-benzopyran-4-one

(2r)-7-hydroxy-6,8-dimethyl-2-[(1e)-prop-1-en-1-yl]-2,3-dihydro-1-benzopyran-4-one

C14H16O3 (232.1099)


   

(3r)-5-methoxy-1'-methylspiro[indole-3,3'-pyrrolidin]-2-ol

(3r)-5-methoxy-1'-methylspiro[indole-3,3'-pyrrolidin]-2-ol

C13H16N2O2 (232.1212)


   

7-hydroxy-6,8-dimethyl-2-(prop-1-en-1-yl)-2,3-dihydro-1-benzopyran-4-one

7-hydroxy-6,8-dimethyl-2-(prop-1-en-1-yl)-2,3-dihydro-1-benzopyran-4-one

C14H16O3 (232.1099)


   

7-ethyl-3,4,7-trimethylisochromene-6,8-dione

7-ethyl-3,4,7-trimethylisochromene-6,8-dione

C14H16O3 (232.1099)


   

(2s)-2-amino-4-[(3-carboxypropyl)-c-hydroxycarbonimidoyl]butanoic acid

(2s)-2-amino-4-[(3-carboxypropyl)-c-hydroxycarbonimidoyl]butanoic acid

C9H16N2O5 (232.1059)


   

(2e,4e)-1-(2,6-dihydroxy-3,5-dimethylphenyl)hexa-2,4-dien-1-one

(2e,4e)-1-(2,6-dihydroxy-3,5-dimethylphenyl)hexa-2,4-dien-1-one

C14H16O3 (232.1099)


   

(1s,3r,4ar,5r,7s,7as)-1,3-dimethoxy-7-methyl-hexahydro-1h-cyclopenta[c]pyran-5,7-diol

(1s,3r,4ar,5r,7s,7as)-1,3-dimethoxy-7-methyl-hexahydro-1h-cyclopenta[c]pyran-5,7-diol

C11H20O5 (232.1311)


   

2-(dimethylamino)-3-(1h-indol-3-yl)propanoic acid

2-(dimethylamino)-3-(1h-indol-3-yl)propanoic acid

C13H16N2O2 (232.1212)


   

1h,1'h-3,3'-biindole

1h,1'h-3,3'-biindole

C16H12N2 (232.1)


   

4,6-dimethoxy-2-methyl-3-(3-methylbut-3-en-1-yn-1-yl)phenol

4,6-dimethoxy-2-methyl-3-(3-methylbut-3-en-1-yn-1-yl)phenol

C14H16O3 (232.1099)


   

2-hydroxy-6-[(1e,3s)-4-hydroxy-3-[(1e)-prop-1-en-1-yl]but-1-en-1-yl]benzaldehyde

2-hydroxy-6-[(1e,3s)-4-hydroxy-3-[(1e)-prop-1-en-1-yl]but-1-en-1-yl]benzaldehyde

C14H16O3 (232.1099)


   

1,6-diethyl (3r)-3-hydroxy-3-methylhexanedioate

1,6-diethyl (3r)-3-hydroxy-3-methylhexanedioate

C11H20O5 (232.1311)


   

methyl (4e,6s,7r,9s)-6,7,9-trihydroxydec-4-enoate

methyl (4e,6s,7r,9s)-6,7,9-trihydroxydec-4-enoate

C11H20O5 (232.1311)


   

(3ar,8ar,9ar)-8a-methyl-3-methylidene-3ah,6h,7h,8h,9h,9ah-naphtho[2,3-b]furan-2,5-dione

(3ar,8ar,9ar)-8a-methyl-3-methylidene-3ah,6h,7h,8h,9h,9ah-naphtho[2,3-b]furan-2,5-dione

C14H16O3 (232.1099)


   

(2e)-3-(2,2-dimethyl-3,4-dihydro-1-benzopyran-6-yl)prop-2-enoic acid

(2e)-3-(2,2-dimethyl-3,4-dihydro-1-benzopyran-6-yl)prop-2-enoic acid

C14H16O3 (232.1099)


   

1-(8-methoxy-2,2-dimethylchromen-6-yl)ethanone

1-(8-methoxy-2,2-dimethylchromen-6-yl)ethanone

C14H16O3 (232.1099)


   

wutaipyranol

wutaipyranol

C14H16O3 (232.1099)


   

(3ar,8s,9as)-8-methyl-3-methylidene-3ah,4h,6h,7h,8h,9h,9ah-azuleno[6,5-b]furan-2,5-dione

(3ar,8s,9as)-8-methyl-3-methylidene-3ah,4h,6h,7h,8h,9h,9ah-azuleno[6,5-b]furan-2,5-dione

C14H16O3 (232.1099)


   

6-[(1e,3e,5e)-hepta-1,3,5-trien-1-yl]-4-methoxy-5-methylpyran-2-one

6-[(1e,3e,5e)-hepta-1,3,5-trien-1-yl]-4-methoxy-5-methylpyran-2-one

C14H16O3 (232.1099)


   

2-hydroxy-6-[4-hydroxy-3-(prop-1-en-1-yl)but-1-en-1-yl]benzaldehyde

2-hydroxy-6-[4-hydroxy-3-(prop-1-en-1-yl)but-1-en-1-yl]benzaldehyde

C14H16O3 (232.1099)


   

8-ethyl-2,3,8-trimethylchromene-4,7-dione

8-ethyl-2,3,8-trimethylchromene-4,7-dione

C14H16O3 (232.1099)


   

6-amino-6-carboxy-2-(trimethylammonio)hexanoate

6-amino-6-carboxy-2-(trimethylammonio)hexanoate

C10H20N2O4 (232.1423)


   

1-(2,4-dihydroxy-3,5-dimethylphenyl)hexa-2,4-dien-1-one

1-(2,4-dihydroxy-3,5-dimethylphenyl)hexa-2,4-dien-1-one

C14H16O3 (232.1099)


   

2-hydroxy-6-[(1e,3r)-4-hydroxy-3-[(1e)-prop-1-en-1-yl]but-1-en-1-yl]benzaldehyde

2-hydroxy-6-[(1e,3r)-4-hydroxy-3-[(1e)-prop-1-en-1-yl]but-1-en-1-yl]benzaldehyde

C14H16O3 (232.1099)


   

(3s,4r,5r)-5-(1,2-dihydroxy-2-methylbutyl)-4-hydroxy-3,5-dimethyloxolan-2-one

(3s,4r,5r)-5-(1,2-dihydroxy-2-methylbutyl)-4-hydroxy-3,5-dimethyloxolan-2-one

C11H20O5 (232.1311)


   

n-[2-(5-methoxy-1h-indol-3-yl)ethyl]ethanimidic acid

n-[2-(5-methoxy-1h-indol-3-yl)ethyl]ethanimidic acid

C13H16N2O2 (232.1212)


   

1h,1'h-2,2'-biindole

1h,1'h-2,2'-biindole

C16H12N2 (232.1)


   

6-(chloromethyl)-3,8-dimethoxy-2-methylocta-1,6-diene

6-(chloromethyl)-3,8-dimethoxy-2-methylocta-1,6-diene

C12H21ClO2 (232.123)


   

(2s)-2-(furan-2-yl)-2-(2-phenylethoxy)ethanol

(2s)-2-(furan-2-yl)-2-(2-phenylethoxy)ethanol

C14H16O3 (232.1099)


   

6-(hydroxymethyl)-6,8-dimethyl-3h,5h,7h-indeno[5,6-c]furan-1-one

6-(hydroxymethyl)-6,8-dimethyl-3h,5h,7h-indeno[5,6-c]furan-1-one

C14H16O3 (232.1099)


   

10-hydroxy-5,8-dimethyl-9-methylidene-12-oxatetracyclo[6.4.0.0¹,¹¹.0³,⁷]dodec-4-en-6-one

10-hydroxy-5,8-dimethyl-9-methylidene-12-oxatetracyclo[6.4.0.0¹,¹¹.0³,⁷]dodec-4-en-6-one

C14H16O3 (232.1099)


   

3-(2,5-dihydroxy-4-methylphenyl)-4,4-dimethylcyclopent-2-en-1-one

3-(2,5-dihydroxy-4-methylphenyl)-4,4-dimethylcyclopent-2-en-1-one

C14H16O3 (232.1099)


   

3-[(3r)-3-hydroxy-2,2-dimethyl-3,4-dihydro-1-benzopyran-6-yl]prop-2-enal

3-[(3r)-3-hydroxy-2,2-dimethyl-3,4-dihydro-1-benzopyran-6-yl]prop-2-enal

C14H16O3 (232.1099)


   

3-[(1e,3e)-penta-1,3-dien-1-yl]-3,4-dihydro-1h-2-benzopyran-4,8-diol

3-[(1e,3e)-penta-1,3-dien-1-yl]-3,4-dihydro-1h-2-benzopyran-4,8-diol

C14H16O3 (232.1099)


   

6-(hepta-1,3,5-trien-1-yl)-4-methoxy-5-methylpyran-2-one

6-(hepta-1,3,5-trien-1-yl)-4-methoxy-5-methylpyran-2-one

C14H16O3 (232.1099)


   

methyl 6,7,9-trihydroxydec-4-enoate

methyl 6,7,9-trihydroxydec-4-enoate

C11H20O5 (232.1311)


   

1-(5-acetyl-2-methoxyphenyl)-3-methylbut-2-en-1-one

1-(5-acetyl-2-methoxyphenyl)-3-methylbut-2-en-1-one

C14H16O3 (232.1099)


   

5-methoxy-1'-methylspiro[indole-3,3'-pyrrolidin]-2-ol

5-methoxy-1'-methylspiro[indole-3,3'-pyrrolidin]-2-ol

C13H16N2O2 (232.1212)


   

(2z)-3-[4-hydroxy-3-(3-methylbut-2-en-1-yl)phenyl]prop-2-enoic acid

(2z)-3-[4-hydroxy-3-(3-methylbut-2-en-1-yl)phenyl]prop-2-enoic acid

C14H16O3 (232.1099)


   

5-(1,2-dihydroxy-2-methylbutyl)-4-hydroxy-3,5-dimethyloxolan-2-one

5-(1,2-dihydroxy-2-methylbutyl)-4-hydroxy-3,5-dimethyloxolan-2-one

C11H20O5 (232.1311)


   

1-(2-hydroxy-4-methoxy-5-methylphenyl)hexa-2,4-dien-1-one

1-(2-hydroxy-4-methoxy-5-methylphenyl)hexa-2,4-dien-1-one

C14H16O3 (232.1099)


   

{n'-[(2s)-1-methoxy-4-methyl-1-oxopentan-2-yl]hydrazinecarbonyl}formic acid

{n'-[(2s)-1-methoxy-4-methyl-1-oxopentan-2-yl]hydrazinecarbonyl}formic acid

C9H16N2O5 (232.1059)


   

(7s)-7-ethyl-3,4,7-trimethylisochromene-6,8-dione

(7s)-7-ethyl-3,4,7-trimethylisochromene-6,8-dione

C14H16O3 (232.1099)


   

1-[6-methoxy-2-(prop-1-en-2-yl)-2,3-dihydro-1-benzofuran-5-yl]ethanone

1-[6-methoxy-2-(prop-1-en-2-yl)-2,3-dihydro-1-benzofuran-5-yl]ethanone

C14H16O3 (232.1099)


   

(3s,4r)-3-[(1e,3e)-penta-1,3-dien-1-yl]-3,4-dihydro-1h-2-benzopyran-4,8-diol

(3s,4r)-3-[(1e,3e)-penta-1,3-dien-1-yl]-3,4-dihydro-1h-2-benzopyran-4,8-diol

C14H16O3 (232.1099)


   

1,6-diethyl 3-hydroxy-3-methylhexanedioate

1,6-diethyl 3-hydroxy-3-methylhexanedioate

C11H20O5 (232.1311)


   

(1s)-1,7-dihydroxy-4-isopropyl-1-methylnaphthalen-2-one

(1s)-1,7-dihydroxy-4-isopropyl-1-methylnaphthalen-2-one

C14H16O3 (232.1099)


   

(3r,6z)-6-(chloromethyl)-3,8-dimethoxy-2-methylocta-1,6-diene

(3r,6z)-6-(chloromethyl)-3,8-dimethoxy-2-methylocta-1,6-diene

C12H21ClO2 (232.123)


   

methyl (2s)-3-(1h-indol-3-yl)-2-(methylamino)propanoate

methyl (2s)-3-(1h-indol-3-yl)-2-(methylamino)propanoate

C13H16N2O2 (232.1212)


   

1-[(2r)-5-methoxy-2-(prop-1-en-2-yl)-2,3-dihydro-1-benzofuran-4-yl]ethanone

1-[(2r)-5-methoxy-2-(prop-1-en-2-yl)-2,3-dihydro-1-benzofuran-4-yl]ethanone

C14H16O3 (232.1099)


   

4-hydroxy-3-[2-(4-hydroxyphenyl)ethyl]cyclohex-2-en-1-one

4-hydroxy-3-[2-(4-hydroxyphenyl)ethyl]cyclohex-2-en-1-one

C14H16O3 (232.1099)


   

5-hydroxy-3-[2-(4-hydroxyphenyl)ethyl]cyclohex-2-en-1-one

5-hydroxy-3-[2-(4-hydroxyphenyl)ethyl]cyclohex-2-en-1-one

C14H16O3 (232.1099)


   

8-methyl-3-methylidene-3ah,4h,6h,7h,8h,9h,9ah-azuleno[6,5-b]furan-2,5-dione

8-methyl-3-methylidene-3ah,4h,6h,7h,8h,9h,9ah-azuleno[6,5-b]furan-2,5-dione

C14H16O3 (232.1099)


   

(8s)-8-ethyl-2,3,8-trimethylchromene-4,5-dione

(8s)-8-ethyl-2,3,8-trimethylchromene-4,5-dione

C14H16O3 (232.1099)


   

methyl 3-(1h-indol-3-yl)-2-(methylamino)propanoate

methyl 3-(1h-indol-3-yl)-2-(methylamino)propanoate

C13H16N2O2 (232.1212)


   

(3s,6's)-5',6'-dimethylspiro[indole-3,2'-[1,5]oxazinan]-2-ol

(3s,6's)-5',6'-dimethylspiro[indole-3,2'-[1,5]oxazinan]-2-ol

C13H16N2O2 (232.1212)


   

(4ar,8ar,9as)-3,8a-dimethyl-4h,4ah,5h,9h,9ah-naphtho[2,3-b]furan-2,8-dione

(4ar,8ar,9as)-3,8a-dimethyl-4h,4ah,5h,9h,9ah-naphtho[2,3-b]furan-2,8-dione

C14H16O3 (232.1099)


   

tetradeca-4,6,12-trien-8,10-diyne-1,3,14-triol

tetradeca-4,6,12-trien-8,10-diyne-1,3,14-triol

C14H16O3 (232.1099)


   

8-methyl-3-methylidene-3ah,4h,4ah,7ah,8h,9h,9ah-azuleno[6,5-b]furan-2,5-dione

8-methyl-3-methylidene-3ah,4h,4ah,7ah,8h,9h,9ah-azuleno[6,5-b]furan-2,5-dione

C14H16O3 (232.1099)


   

(2z,6e)-3-(chloromethyl)-1,8-dimethoxy-7-methylocta-2,6-diene

(2z,6e)-3-(chloromethyl)-1,8-dimethoxy-7-methylocta-2,6-diene

C12H21ClO2 (232.123)


   

3-[(2r,5r)-5-(furan-2-ylmethyl)-5-methyloxolan-2-yl]furan

3-[(2r,5r)-5-(furan-2-ylmethyl)-5-methyloxolan-2-yl]furan

C14H16O3 (232.1099)


   

11-acetyl-7,11-diazatricyclo[7.3.1.0²,⁷]trideca-2,4-dien-6-one

11-acetyl-7,11-diazatricyclo[7.3.1.0²,⁷]trideca-2,4-dien-6-one

C13H16N2O2 (232.1212)


   

(6r)-6-(hydroxymethyl)-6,8-dimethyl-3h,5h,7h-indeno[5,6-c]furan-1-one

(6r)-6-(hydroxymethyl)-6,8-dimethyl-3h,5h,7h-indeno[5,6-c]furan-1-one

C14H16O3 (232.1099)


   

(2s)-5-amino-2-[(3-carboxy-1-hydroxypropylidene)amino]pentanoic acid

(2s)-5-amino-2-[(3-carboxy-1-hydroxypropylidene)amino]pentanoic acid

C9H16N2O5 (232.1059)


   

5',6'-dimethylspiro[indole-3,2'-[1,5]oxazinan]-2-ol

5',6'-dimethylspiro[indole-3,2'-[1,5]oxazinan]-2-ol

C13H16N2O2 (232.1212)


   

(2s,4s)-2-amino-4-hydroxy-4-{[(2s)-2-methylbutyl]-c-hydroxycarbonimidoyl}butanoic acid

(2s,4s)-2-amino-4-hydroxy-4-{[(2s)-2-methylbutyl]-c-hydroxycarbonimidoyl}butanoic acid

C10H20N2O4 (232.1423)


   

1',2-dimethyl-1,2-dihydrospiro[3,1-benzoxazine-4,3'-pyrrolidin]-2'-one

1',2-dimethyl-1,2-dihydrospiro[3,1-benzoxazine-4,3'-pyrrolidin]-2'-one

C13H16N2O2 (232.1212)


   

2-amino-4-hydroxy-4-[(2-methylbutyl)-c-hydroxycarbonimidoyl]butanoic acid

2-amino-4-hydroxy-4-[(2-methylbutyl)-c-hydroxycarbonimidoyl]butanoic acid

C10H20N2O4 (232.1423)


   

8-ethyl-2,3,8-trimethylchromene-4,5-dione

8-ethyl-2,3,8-trimethylchromene-4,5-dione

C14H16O3 (232.1099)


   

3-(3-methoxy-5-phenylfuran-2-yl)propan-1-ol

3-(3-methoxy-5-phenylfuran-2-yl)propan-1-ol

C14H16O3 (232.1099)


   

1-[6-methoxy-2-(prop-1-en-2-yl)-1-benzofuran-5-yl]ethanol

1-[6-methoxy-2-(prop-1-en-2-yl)-1-benzofuran-5-yl]ethanol

C14H16O3 (232.1099)


   

8-hydroxy-4,7,7-trimethyl-3h,6h,8h-indeno[4,5-c]furan-1-one

8-hydroxy-4,7,7-trimethyl-3h,6h,8h-indeno[4,5-c]furan-1-one

C14H16O3 (232.1099)


   

10-(methylsulfanyl)-2-oxodecanoic acid

10-(methylsulfanyl)-2-oxodecanoic acid

C11H20O3S (232.1133)


   

3-(2,2-dimethyl-3,4-dihydro-1-benzopyran-6-yl)prop-2-enoic acid

3-(2,2-dimethyl-3,4-dihydro-1-benzopyran-6-yl)prop-2-enoic acid

C14H16O3 (232.1099)


   

(1r)-1-[6-methoxy-2-(prop-1-en-2-yl)-1-benzofuran-5-yl]ethanol

(1r)-1-[6-methoxy-2-(prop-1-en-2-yl)-1-benzofuran-5-yl]ethanol

C14H16O3 (232.1099)


   

(2s,4r)-1',2-dimethyl-1,2-dihydrospiro[3,1-benzoxazine-4,3'-pyrrolidin]-2'-one

(2s,4r)-1',2-dimethyl-1,2-dihydrospiro[3,1-benzoxazine-4,3'-pyrrolidin]-2'-one

C13H16N2O2 (232.1212)


   

(2e)-3-[4-hydroxy-3-(3-methylbut-2-en-1-yl)phenyl]prop-2-enoic acid

(2e)-3-[4-hydroxy-3-(3-methylbut-2-en-1-yl)phenyl]prop-2-enoic acid

C14H16O3 (232.1099)


   

8a-methyl-3-methylidene-3ah,6h,7h,8h,9h,9ah-naphtho[2,3-b]furan-2,5-dione

8a-methyl-3-methylidene-3ah,6h,7h,8h,9h,9ah-naphtho[2,3-b]furan-2,5-dione

C14H16O3 (232.1099)


   

(1s,3s,7r,8r,10r,11r)-10-hydroxy-5,8-dimethyl-9-methylidene-12-oxatetracyclo[6.4.0.0¹,¹¹.0³,⁷]dodec-4-en-6-one

(1s,3s,7r,8r,10r,11r)-10-hydroxy-5,8-dimethyl-9-methylidene-12-oxatetracyclo[6.4.0.0¹,¹¹.0³,⁷]dodec-4-en-6-one

C14H16O3 (232.1099)


   

3-(furan-2-yl)-3a,7-dimethyl-3,4,5,6-tetrahydro-2-benzofuran-1-one

3-(furan-2-yl)-3a,7-dimethyl-3,4,5,6-tetrahydro-2-benzofuran-1-one

C14H16O3 (232.1099)


   

(8s)-8-hydroxy-4,7,7-trimethyl-3h,6h,8h-indeno[4,5-c]furan-1-one

(8s)-8-hydroxy-4,7,7-trimethyl-3h,6h,8h-indeno[4,5-c]furan-1-one

C14H16O3 (232.1099)


   

(2s)-7-hydroxy-6,8-dimethyl-2-[(1e)-prop-1-en-1-yl]-2,3-dihydro-1-benzopyran-4-one

(2s)-7-hydroxy-6,8-dimethyl-2-[(1e)-prop-1-en-1-yl]-2,3-dihydro-1-benzopyran-4-one

C14H16O3 (232.1099)


   

1-(2,6-dihydroxy-3,5-dimethylphenyl)hexa-2,4-dien-1-one

1-(2,6-dihydroxy-3,5-dimethylphenyl)hexa-2,4-dien-1-one

C14H16O3 (232.1099)


   

7-(3-methylbutoxy)chromen-2-one

7-(3-methylbutoxy)chromen-2-one

C14H16O3 (232.1099)


   

(8s)-8-ethyl-2,3,8-trimethylchromene-4,7-dione

(8s)-8-ethyl-2,3,8-trimethylchromene-4,7-dione

C14H16O3 (232.1099)


   

5-methylindolo[3,2-c]quinoline

5-methylindolo[3,2-c]quinoline

C16H12N2 (232.1)


   

2-hydroxy-6-[(1e)-4-hydroxy-3-[(1e)-prop-1-en-1-yl]but-1-en-1-yl]benzaldehyde

2-hydroxy-6-[(1e)-4-hydroxy-3-[(1e)-prop-1-en-1-yl]but-1-en-1-yl]benzaldehyde

C14H16O3 (232.1099)


   

(3s)-8,8-dimethyl-2h,3h,4h-pyrano[2,3-f]chromen-3-ol

(3s)-8,8-dimethyl-2h,3h,4h-pyrano[2,3-f]chromen-3-ol

C14H16O3 (232.1099)


   

n-[1-hydroxy-3-(1h-indol-3-yl)propan-2-yl]ethanimidic acid

n-[1-hydroxy-3-(1h-indol-3-yl)propan-2-yl]ethanimidic acid

C13H16N2O2 (232.1212)


   
   

3-[5-(furan-2-ylmethyl)-5-methyloxolan-2-yl]furan

3-[5-(furan-2-ylmethyl)-5-methyloxolan-2-yl]furan

C14H16O3 (232.1099)


   

(1s,9r)-11-acetyl-7,11-diazatricyclo[7.3.1.0²,⁷]trideca-2,4-dien-6-one

(1s,9r)-11-acetyl-7,11-diazatricyclo[7.3.1.0²,⁷]trideca-2,4-dien-6-one

C13H16N2O2 (232.1212)


   

2-[(1z)-4-hydroxy-3-methylidenebut-1-en-1-yl]-4-[(1z)-3-hydroxyprop-1-en-1-yl]phenol

2-[(1z)-4-hydroxy-3-methylidenebut-1-en-1-yl]-4-[(1z)-3-hydroxyprop-1-en-1-yl]phenol

C14H16O3 (232.1099)


   

(2s,3r)-2-{[(2s)-2-amino-1-hydroxy-4-methylpentylidene]amino}-3-hydroxybutanoic acid

(2s,3r)-2-{[(2s)-2-amino-1-hydroxy-4-methylpentylidene]amino}-3-hydroxybutanoic acid

C10H20N2O4 (232.1423)


   

1-[(2s)-6-methoxy-2-(prop-1-en-2-yl)-2,3-dihydro-1-benzofuran-5-yl]ethanone

1-[(2s)-6-methoxy-2-(prop-1-en-2-yl)-2,3-dihydro-1-benzofuran-5-yl]ethanone

C14H16O3 (232.1099)


   

3-(furan-3-yl)-3a,7-dimethyl-3,4,5,7a-tetrahydro-2-benzofuran-1-one

3-(furan-3-yl)-3a,7-dimethyl-3,4,5,7a-tetrahydro-2-benzofuran-1-one

C14H16O3 (232.1099)


   

8,8-dimethyl-2h,3h,4h-pyrano[2,3-f]chromen-3-ol

8,8-dimethyl-2h,3h,4h-pyrano[2,3-f]chromen-3-ol

C14H16O3 (232.1099)


   

(2s)-7-hydroxy-6,8-dimethyl-2-(prop-1-en-1-yl)-2,3-dihydro-1-benzopyran-4-one

(2s)-7-hydroxy-6,8-dimethyl-2-(prop-1-en-1-yl)-2,3-dihydro-1-benzopyran-4-one

C14H16O3 (232.1099)


   

3-(furan-3-yl)-3a,7-dimethyl-3,4,5,6-tetrahydro-2-benzofuran-1-one

3-(furan-3-yl)-3a,7-dimethyl-3,4,5,6-tetrahydro-2-benzofuran-1-one

C14H16O3 (232.1099)


   

(3r,3ar,7ar)-3-(furan-3-yl)-3a,7-dimethyl-3,4,5,7a-tetrahydro-2-benzofuran-1-one

(3r,3ar,7ar)-3-(furan-3-yl)-3a,7-dimethyl-3,4,5,7a-tetrahydro-2-benzofuran-1-one

C14H16O3 (232.1099)


   

(3r,3ar,7as)-3-(furan-3-yl)-3a,7-dimethyl-3,4,5,7a-tetrahydro-2-benzofuran-1-one

(3r,3ar,7as)-3-(furan-3-yl)-3a,7-dimethyl-3,4,5,7a-tetrahydro-2-benzofuran-1-one

C14H16O3 (232.1099)


   

(1r,2s,5r,6s,9s,10r)-5,10-dimethyl-3-oxatetracyclo[7.4.0.0¹,¹⁰.0²,⁶]tridec-12-ene-4,11-dione

(1r,2s,5r,6s,9s,10r)-5,10-dimethyl-3-oxatetracyclo[7.4.0.0¹,¹⁰.0²,⁶]tridec-12-ene-4,11-dione

C14H16O3 (232.1099)


   

3-[(2s)-2-(2-hydroxypropan-2-yl)-2,3-dihydro-1-benzofuran-5-yl]prop-2-enal

3-[(2s)-2-(2-hydroxypropan-2-yl)-2,3-dihydro-1-benzofuran-5-yl]prop-2-enal

C14H16O3 (232.1099)


   

6-(chloromethyl)-1,8-dimethoxy-2-methylocta-2,6-diene

6-(chloromethyl)-1,8-dimethoxy-2-methylocta-2,6-diene

C12H21ClO2 (232.123)


   

(3s,4r,5s)-5-(1,3-dihydroxy-2-methylbutyl)-4-hydroxy-3,5-dimethyloxolan-2-one

(3s,4r,5s)-5-(1,3-dihydroxy-2-methylbutyl)-4-hydroxy-3,5-dimethyloxolan-2-one

C11H20O5 (232.1311)


   

(3r,3ar)-3-(furan-2-yl)-3a,7-dimethyl-3,4,5,6-tetrahydro-2-benzofuran-1-one

(3r,3ar)-3-(furan-2-yl)-3a,7-dimethyl-3,4,5,6-tetrahydro-2-benzofuran-1-one

C14H16O3 (232.1099)


   

(2e)-3-[(2s)-2-(2-hydroxypropan-2-yl)-2,3-dihydro-1-benzofuran-5-yl]prop-2-enal

(2e)-3-[(2s)-2-(2-hydroxypropan-2-yl)-2,3-dihydro-1-benzofuran-5-yl]prop-2-enal

C14H16O3 (232.1099)


   

(1s,3r,7s)-1,3-dimethoxy-7-methyl-hexahydro-1h-cyclopenta[c]pyran-5,7-diol

(1s,3r,7s)-1,3-dimethoxy-7-methyl-hexahydro-1h-cyclopenta[c]pyran-5,7-diol

C11H20O5 (232.1311)


   

7-hydroxy-6-(3-methylbut-2-en-1-yl)-3,4-dihydro-1-benzopyran-2-one

7-hydroxy-6-(3-methylbut-2-en-1-yl)-3,4-dihydro-1-benzopyran-2-one

C14H16O3 (232.1099)


   

1,2,8-trimethoxy-6-methylnaphthalene

1,2,8-trimethoxy-6-methylnaphthalene

C14H16O3 (232.1099)